UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
Washington,
D.C. 20549
Form 10-Q
(Mark
One)
☒ QUARTERLY
REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
FOR
THE QUARTERLY PERIOD ENDED: June 30, 2024
☐ TRANSITION
REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For
the transition period from __________ to __________
Commission
File Number: 333-147980
ORIGINCLEAR,
INC.
(Exact name of registrant
as specified in its charter)
Nevada | | 26-0287664 |
(State or other jurisdiction of incorporation or organization) | | (I.R.S. Employer Identification No.) |
13575 58th Street
North
Suite 200
Clearwater, FL 33760
(Address of principal
executive offices, Zip Code)
(727) 440-4603
(Registrant’s telephone
number, including area code)
Securities registered
pursuant to Section 12(b) of the Act:
Title of each class | | Ticker symbol(s) | | Name of each exchange on which registered |
N/A | | N/A | | N/A |
Indicate by check mark
whether the registrant (1) filed all reports required to be filed by Section 13 or 15(d) of the Exchange Act of 1934 during the preceding
12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing
requirements for the past 90 days. Yes ☒ No ☐
Indicate by check mark
whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation
S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit
such files). Yes ☒ No ☐
Indicate by check mark
whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an
emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller
reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.
Large accelerated filer | ☐ | Accelerated filer | ☐ |
Non-accelerated filer | ☒ | Smaller reporting company | ☒ |
| Emerging growth company | ☐ |
If an emerging growth
company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or
revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Indicate by check mark
whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No ☒
As of August 13, 2024,
there were 1,585,533,032 shares of common stock, par value $0.0001 per share, issued and outstanding.
TABLE OF CONTENTS
PART
I - FINANCIAL INFORMATION
ITEM 1. FINANCIAL STATEMENTS
ORIGINCLEAR, INC. AND SUBSIDIARIES
Condensed Consolidated Balance Sheets
| |
June 30, | | |
December 31, | |
| |
2024 | | |
2023 | |
| |
(Unaudited) | | |
| |
ASSETS | |
| | |
| |
CURRENT ASSETS | |
| | |
| |
Cash and cash equivalents | |
$ | 32,899 | | |
$ | 114,639 | |
Current assets held-for-sale | |
| 1,961,320 | | |
| 2,338,798 | |
Fair value investment in securities | |
| 36,167 | | |
| 36,167 | |
Prepaid expenses | |
| 11,048 | | |
| - | |
TOTAL CURRENT ASSETS | |
| 2,041,434 | | |
| 2,489,604 | |
| |
| | | |
| | |
Net property and equipment | |
| 130,232 | | |
| 143,366 | |
Net property and equipment held-for-sale | |
| 2,006 | | |
| 3,370 | |
NET PROPERTY AND EQUIPMENT | |
| 132,238 | | |
| 146,736 | |
OTHER ASSETS | |
| | | |
| | |
Receivable on sale of asset | |
| 33,000 | | |
| 99,000 | |
Non-current assets held- for-sale | |
| 418,000 | | |
| 400,000 | |
Fair value investment-securities | |
| 3,200 | | |
| 3,200 | |
Trademark | |
| 4,467 | | |
| 4,467 | |
TOTAL OTHER ASSETS | |
| 458,667 | | |
| 506,667 | |
| |
| | | |
| | |
TOTAL ASSETS | |
$ | 2,632,339 | | |
$ | 3,143,007 | |
| |
| | | |
| | |
LIABILITIES AND SHAREHOLDERS’ DEFICIT | |
| | | |
| | |
CURRENT LIABILITIES: | |
| | | |
| | |
Accounts payable and other payable | |
$ | 818,125 | | |
$ | 647,483 | |
Accrued expenses | |
| 1,867,045 | | |
| 1,774,513 | |
Cumulative preferred stock dividends payable | |
| 613,215 | | |
| 523,403 | |
Customer deposit | |
| 2,950 | | |
| 2,950 | |
Secured loans payable | |
| - | | |
| 30,646 | |
Loans payable, SBA | |
| 145,890 | | |
| 147,217 | |
Derivative liabilities | |
| 14,336,270 | | |
| 7,742,759 | |
Series F 8% Preferred Stock, 50 and 60 shares issued and outstanding, respectively, redeemable value of $50,000 and $60,000 respectively | |
| 50,000 | | |
| 60,000 | |
Series G 8% Preferred Stock, 25 and 25 shares issued and outstanding, respectively, redeemable value of $25,000 and $25,000, respectively | |
| 25,000 | | |
| 25,000 | |
Series I 8% Preferred Stock, 25 and 25 shares issued and outstanding, respectively, redeemable value of $25,000 and $25,000, respectively | |
| 25,000 | | |
| 25,000 | |
Series K 8% Preferred Stock, 297.15 and 307.15 shares issued and outstanding, respectively, respectively, redeemable value of $297,150 and $307,150, respectively | |
| 297,150 | | |
| 307,150 | |
Convertible promissory notes, net of discount of $0 and $0, respectively | |
| 597,944 | | |
| 2,472,944 | |
Current liabilities held-for-sale | |
| 25,516,270 | | |
| 20,980,431 | |
TOTAL CURRENT LIABILITIES | |
| 44,294,859 | | |
| 34,739,496 | |
| |
| | | |
| | |
Long Term Liabilities | |
| | | |
| | |
Convertible promissory notes, net of discount of $0 and $0, respectively | |
| 2,019,747 | | |
| 144,747 | |
TOTAL LONG TERM LIABILITIES | |
| 2,019,747 | | |
| 144,747 | |
| |
| | | |
| | |
TOTAL LIABILITIES | |
| 46,314,606 | | |
| 34,884,243 | |
| |
| | | |
| | |
COMMITMENTS AND CONTINGENCIES (Note 13) | |
| | | |
| | |
| |
| | | |
| | |
Series J Convertible Preferred Stock, 210 and 210 shares issued and outstanding, respectively, redeemable value of $210,000 and $210,000, respectively | |
| 210,000 | | |
| 210,000 | |
Series L Convertible Preferred Stock, 320,495 and 320,495 shares issued
and outstanding, respectively, redeemable value of $320,495 and $320,495, respectively | |
| 320,495 | | |
| 320,495 | |
Series M Preferred Stock, 40,300 and 40,300 shares issued and outstanding, respectively, redeemable value of $1,007,500 and $1,007,500, respectively | |
| 1,007,500 | | |
| 1,007,500 | |
Series O 8% Convertible Preferred Stock, 185 and 190 shares issued and outstanding, respectively, redeemable value of $185,000 and $190,000, respectively | |
| 185,000 | | |
| 190,000 | |
Series P Convertible Preferred Stock, 30 and 30 shares issued and outstanding, respectively redeemable value of $30,000 and $30,000, respectively | |
| 30,000 | | |
| 30,000 | |
Series Q 12% Convertible Preferred Stock, 410 and 420 shares issued and outstanding, respectively, redeemable value of $410,000 and $420,000, respectively | |
| 410,000 | | |
| 420,000 | |
Series R 12% Convertible Preferred Stock, 1,473 and 1,608 shares issued and outstanding, respectively, redeemable value of $1,473,000 and $1,608,000, respectively | |
| 1,473,000 | | |
| 1,608,000 | |
Series S 12% Convertible Preferred Stock, 110 and 120 shares issued and outstanding, respectively, redeemable value of $110,000 and $120,000, respectively | |
| 110,000 | | |
| 120,000 | |
Series U Convertible Preferred Stock, 270 and 270 shares issued and outstanding, respectively, redeemable value of $270,000 and $270,000, respectively | |
| 270,000 | | |
| 270,000 | |
Series W 12% Convertible Preferred Stock, 696.50 and 886.5 shares issued and outstanding, respectively, redeemable value of $696,500 and $886,500, respectively | |
| 696,500 | | |
| 886,500 | |
Series Y Convertible Preferred Stock, 25.9 and 24.6 shares issued and outstanding, respectively, redeemable value of $2,597,327 and $2,460,227, respectively | |
| 2,595,327 | | |
| 2,460,227 | |
| |
| 7,307,822 | | |
| 7,522,722 | |
| |
| | | |
| | |
SHAREHOLDERS’ DEFICIT | |
| | | |
| | |
Preferred stock, $0.0001 par value, 600,000,000 shares authorized 31,500,000 and 31,5000,000 shares of Series D-1 issued and outstanding, respectively | |
| 3,150 | | |
| 3,150 | |
1,000 and 1,000 shares of Series C issued and outstanding, respectively | |
| - | | |
| - | |
Subscription payable for purchase of equipment | |
| 100,000 | | |
| 100,000 | |
Common stock, $0.0001 par value, 16,000,000,0000 shares authorized
1,613,089,087 and 1,399,782,046 equity shares issued and outstanding, respectively | |
| 161,309 | | |
| 139,978 | |
Additional paid in capital - Common stock | |
| 82,490,747 | | |
| 81,949,274 | |
Noncontrolling interest | |
| (2,593,979 | ) | |
| (2,239,493 | ) |
Accumulated other comprehensive loss | |
| (132 | ) | |
| (132 | ) |
Accumulated deficit | |
| (131,151,184 | ) | |
| (119,216,735 | ) |
TOTAL SHAREHOLDERS’ DEFICIT | |
| (50,990,089 | ) | |
| (39,263,958 | ) |
| |
| | | |
| | |
TOTAL LIABILITIES AND SHAREHOLDERS’ DEFICIT | |
$ | 2,632,339 | | |
$ | 3,143,007 | |
See accompanying Notes to Consolidated Financial
Statements.
ORIGINCLEAR, INC.
AND SUBSIDIARIES
Condensed Consolidated Statements of Operations
(Unaudited)
| |
Three Months Ended June 30, | | |
Six Months Ended June 30, | |
| |
2024 | | |
2023 | | |
2024 | | |
2023 | |
| |
| | |
| | |
| | |
| |
Revenue | |
$ | - | | |
$ | 6,573 | | |
$ | 6,573 | | |
$ | 13,146 | |
Cost of revenue | |
| 6,552 | | |
| 6,463 | | |
| 13,134 | | |
| 13,153 | |
Gross (loss) profit | |
| (6,552 | ) | |
| 110 | | |
| (6,561 | ) | |
| (7 | ) |
| |
| | | |
| | | |
| | | |
| | |
Operating expenses | |
| | | |
| | | |
| | | |
| | |
Selling and marketing expenses | |
| 605,918 | | |
| 605,636 | | |
| 1,132,558 | | |
| 1,402,255 | |
General and administrative expenses | |
| 730,573 | | |
| 638,601 | | |
| 1,623,873 | | |
| 1,665,057 | |
Total Operating expenses | |
| 1,336,491 | | |
| 1,244,237 | | |
| 2,756,431 | | |
| 3,067,312 | |
| |
| | | |
| | | |
| | | |
| | |
Loss from Operations | |
| (1,343,043 | ) | |
| (1,244,127 | ) | |
| (2,762,992 | ) | |
| (3,067,319 | ) |
| |
| | | |
| | | |
| | | |
| | |
OTHER INCOME (EXPENSE) | |
| | | |
| | | |
| | | |
| | |
Other income | |
| - | | |
| 23,416 | | |
| - | | |
| 23,416 | |
Impairment of receivable from SPAC | |
| - | | |
| - | | |
| - | | |
| (50,000 | ) |
Gain on write off of loans payable | |
| 30,646 | | |
| - | | |
| 30,646 | | |
| - | |
Unrealized loss on investment securities | |
| - | | |
| - | | |
| - | | |
| (4,521 | ) |
(Loss) gain on conversion of stock | |
| 567,500 | | |
| (1,802,443 | ) | |
| 1,255,178 | | |
| 5,403,828 | |
Gain (loss) on net change in derivative liability and conversion of debt | |
| 6,173,683 | | |
| (1,049,498 | ) | |
| (6,593,511 | ) | |
| 2,825,879 | |
Interest and dividend expense | |
| (165,585 | ) | |
| (239,105 | ) | |
| (352,567 | ) | |
| (462,545 | ) |
TOTAL OTHER INCOME (EXPENSE) | |
| 6,606,244 | | |
| (3,067,630 | ) | |
| (5,660,254 | ) | |
| 7,736,057 | |
| |
| | | |
| | | |
| | | |
| | |
Net income (loss) from continuing operations | |
| 5,263,201 | | |
| (4,311,757 | ) | |
| (8,423,246 | ) | |
| 4,668,738 | |
Net loss from assets held-for-sale | |
| (1,655,853 | ) | |
| (3,373,086 | ) | |
| (3,865,689 | ) | |
| (9,271,546 | ) |
Net income (loss) | |
$ | 3,607,348 | | |
$ | (7,684,843 | ) | |
$ | (12,288,935 | ) | |
$ | (4,602,808 | ) |
| |
| | | |
| | | |
| | | |
| | |
Basic and fully diluted earnings (loss) per share from continuing operations | |
$ | 0.00 | | |
$ | (0.00 | ) | |
$ | (0.01 | ) | |
$ | (0.00 | ) |
Basic and fully diluted (loss) earnings per share from assets held-for-sale | |
$ | (0.00 | ) | |
$ | (0.00 | ) | |
$ | (0.00 | ) | |
$ | (0.01 | ) |
BASIC AND DILUTED | |
$ | 0.00 | | |
$ | (0.01 | ) | |
$ | (0.01 | ) | |
$ | (0.01 | ) |
| |
| | | |
| | | |
| | | |
| | |
WEIGHTED-AVERAGE COMMON SHARES OUTSTANDING, BASIC AND DILUTED | |
| 1,558,824,206 | | |
| 1,195,322,992 | | |
| 1,501,184,304 | | |
| 1,243,518,367 | |
ORIGINCLEAR, INC. AND SUBSIDIARIES
Condensed Consolidated Statements of Shareholders’ Deficit
(Unaudited)
| |
SIX
MONTHS ENDED JUNE 30, 2023 | |
| |
Preferred
stock | | |
Mezzanine | | |
Common
Stock | | |
Additional
Paid-in- | | |
Subscription | | |
Other
Comprehensive | | |
Noncontrolling | | |
Accumulated | | |
| |
| |
Shares | | |
Amount | | |
Equity | | |
Shares | | |
Amount | | |
Capital | | |
Payable | | |
Loss | | |
Interest | | |
Deficit | | |
Total | |
Balance
at December 31, 2022 | |
| 32,502,475 | | |
| 3,150 | | |
$ | 10,866,772 | | |
| 1,013,369,185 | | |
$ | 101,337 | | |
$ | 82,745,503 | | |
$ | 100,000 | | |
$ | (132 | ) | |
$ | - | | |
$ | (108,966,645 | ) | |
$ | (26,016,787 | ) |
Common
stock issued for cash per equity financing agreement | |
| - | | |
| - | | |
| - | | |
| 18,645,028 | | |
| 1,865 | | |
| 128,719 | | |
| - | | |
| - | | |
| - | | |
| - | | |
| 130,584 | |
Common
stock issued upon conversion of convertible promissory note | |
| - | | |
| - | | |
| - | | |
| 55,788,402 | | |
| 5,579 | | |
| 161,786 | | |
| - | | |
| - | | |
| - | | |
| - | | |
| 167,365 | |
Common
stock issued at fair value for services | |
| - | | |
| - | | |
| - | | |
| 45,217,435 | | |
| 4,521 | | |
| 420,405 | | |
| - | | |
| - | | |
| - | | |
| - | | |
| 424,926 | |
Common
stock issued for conversion of Series O Preferred stock | |
| - | | |
| - | | |
| (40,000 | ) | |
| 7,722,008 | | |
| 772 | | |
| 39,228 | | |
| - | | |
| - | | |
| - | | |
| - | | |
| 40,000 | |
Common
stock issued for conversion of Series Q Preferred stock | |
| - | | |
| - | | |
| (55,000 | ) | |
| 11,490,310 | | |
| 1,149 | | |
| 53,851 | | |
| - | | |
| - | | |
| - | | |
| - | | |
| 55,000 | |
Common
stock issued for conversion of Series R Preferred stock | |
| - | | |
| - | | |
| (720,000 | ) | |
| 146,475,763 | | |
| 14,648 | | |
| 705,352 | | |
| - | | |
| - | | |
| - | | |
| - | | |
| 720,000 | |
Common
stock issued for conversion of Series S Preferred stock | |
| - | | |
| - | | |
| (50,000 | ) | |
| 8,864,250 | | |
| 886 | | |
| 49,114 | | |
| - | | |
| - | | |
| - | | |
| - | | |
| 50,000 | |
Common
stock issued for conversion of Series U Preferred stock | |
| - | | |
| - | | |
| (65,000 | ) | |
| 9,078,212 | | |
| 908 | | |
| 64,092 | | |
| - | | |
| - | | |
| - | | |
| - | | |
| 65,000 | |
Common
stock issued for conversion of Series Y Preferred stock | |
| - | | |
| - | | |
| (1,330,000 | ) | |
| 233,043,093 | | |
| 23,305 | | |
| 1,306,695 | | |
| - | | |
| - | | |
| - | | |
| - | | |
| 1,330,000 | |
Common
stock issued for conversion of Series Z Preferred stock | |
| - | | |
| - | | |
| (250,000 | ) | |
| 61,728,395 | | |
| 6,173 | | |
| 243,827 | | |
| - | | |
| - | | |
| - | | |
| - | | |
| 250,000 | |
Common
stock issued for Series O Preferred stock dividends | |
| - | | |
| - | | |
| - | | |
| 498,280 | | |
| 50 | | |
| (50 | ) | |
| - | | |
| - | | |
| - | | |
| - | | |
| - | |
Common
stock issued for conversion settlement agreements | |
| - | | |
| - | | |
| - | | |
| 265,181,982 | | |
| 26,518 | | |
| (26,518 | ) | |
| - | | |
| - | | |
| - | | |
| - | | |
| - | |
Common
stock issued for alternate vesting | |
| - | | |
| - | | |
| - | | |
| 11,584,932 | | |
| 1,158 | | |
| 119,382 | | |
| - | | |
| - | | |
| - | | |
| - | | |
| 120,540 | |
Common
stock issued through a Reg A to investors for cash | |
| - | | |
| - | | |
| - | | |
| 7,500 | | |
| 1 | | |
| 37,499 | | |
| - | | |
| - | | |
| - | | |
| - | | |
| 37,500 | |
Issuance
of Series A Preferred stock granted to Series Y investors | |
| 209 | | |
| - | | |
| - | | |
| - | | |
| - | | |
| 23,588 | | |
| - | | |
| - | | |
| - | | |
| - | | |
| 23,588 | |
Issuance
of Series B Preferred stock granted to investors | |
| 367,400 | | |
| 37 | | |
| - | | |
| - | | |
| - | | |
| 132,227 | | |
| - | | |
| - | | |
| - | | |
| - | | |
| 132,264 | |
Exchange
of Series K Preferred stock for Series W Preferred stock | |
| - | | |
| - | | |
| 100,000 | | |
| - | | |
| - | | |
| - | | |
| - | | |
| - | | |
| - | | |
| - | | |
| - | |
Issuance
of Series Y Preferred stock through a private placement | |
| - | | |
| - | | |
| 376,300 | | |
| - | | |
| - | | |
| - | | |
| - | | |
| - | | |
| - | | |
| - | | |
| - | |
Exchange
of Series R Preferred stock for WODI secured convertible note | |
| - | | |
| - | | |
| (100,000 | ) | |
| - | | |
| - | | |
| - | | |
| - | | |
| - | | |
| - | | |
| - | | |
| - | |
Exchange
of Series X Preferred stock for WODI secured convertible note | |
| - | | |
| - | | |
| (250,000 | ) | |
| - | | |
| - | | |
| - | | |
| - | | |
| - | | |
| - | | |
| - | | |
| - | |
Return
of investment for Series Y Preferred stock | |
| - | | |
| - | | |
| (10,000 | ) | |
| - | | |
| - | | |
| - | | |
| - | | |
| - | | |
| - | | |
| - | | |
| - | |
Redemption
of common stock for note purchase agreements | |
| - | | |
| - | | |
| - | | |
| (589,253,845 | ) | |
| (58,925 | ) | |
| (5,344,903 | ) | |
| - | | |
| - | | |
| - | | |
| - | | |
| (5,403,828 | ) |
Net
Loss | |
| - | | |
| - | | |
| - | | |
| - | | |
| - | | |
| - | | |
| - | | |
| - | | |
| | | |
| (4,602,808 | ) | |
| (4,602,808 | ) |
Balance
at June 30, 2023 (unaudited) | |
| 32,870,084 | | |
$ | 3,187 | | |
$ | 8,473,072 | | |
| 1,299,440,930 | | |
$ | 129,945 | | |
$ | 80,859,797 | | |
$ | 100,000 | | |
$ | (132 | ) | |
$ | - | | |
$ | (113,569,453 | ) | |
$ | (32,476,656 | ) |
ORIGINCLEAR,
INC. AND SUBSIDIARIES
Condensed Consolidated Statements of Shareholders’ Deficit
(Unaudited)
| |
SIX
MONTHS ENDED JUNE 30, 2024 | |
| |
Preferred
stock | | |
Mezzanine | | |
Common
stock | | |
Additional
Paid-in | | |
Subscription | | |
Other
Comprehensive | | |
Noncontrolling | | |
Accumulated | | |
| |
| |
Shares | | |
Amount | | |
Equity | | |
Shares | | |
Amount | | |
Capital | | |
Payable | | |
loss | | |
Interest | | |
Deficit | | |
Total | |
Balance
at December 31, 2023 | |
| 31,501,000 | | |
| 3,150 | | |
$ | 7,522,722 | | |
| 1,399,782,046 | | |
$ | 139,978 | | |
$ | 81,949,274 | | |
$ | 100,000 | | |
$ | (132 | ) | |
$ | (2,239,493 | ) | |
$ | (119,216,735 | ) | |
$ | (39,263,958 | ) |
Rounding | |
| - | | |
| - | | |
| - | | |
| - | | |
| -1 | | |
| | | |
| - | | |
| - | | |
| - | | |
| - | | |
| -1 | |
Shares
redeemed/cancelled for Note Purchase Agreement | |
| - | | |
| - | | |
| - | | |
| (139,560,037 | ) | |
| (13,956 | ) | |
| (1,241,222 | ) | |
| - | | |
| - | | |
| - | | |
| - | | |
| (1,255,178 | ) |
Common
stock issued for alternative vesting | |
| - | | |
| - | | |
| - | | |
| 20,937,829 | | |
| 2,094 | | |
| 167,505 | | |
| - | | |
| - | | |
| - | | |
| - | | |
| 169,599 | |
Common
stock issued for conversion settlement | |
| - | | |
| - | | |
| - | | |
| 122,213,744 | | |
| 12,221 | | |
| (12,221 | ) | |
| - | | |
| - | | |
| - | | |
| - | | |
| - | |
Common
stock issued for conversion of Series O Preferred stock | |
| - | | |
| - | | |
| (5,000 | ) | |
| 965,252 | | |
| 97 | | |
| 4,903 | | |
| - | | |
| - | | |
| - | | |
| - | | |
| 5,000 | |
Common
stock issued for conversion of Series Q Preferred stock | |
| - | | |
| - | | |
| (20,000 | ) | |
| 4,576,458 | | |
| 458 | | |
| 19,542 | | |
| - | | |
| - | | |
| - | | |
| - | | |
| 20,000 | |
Common
stock issued for conversion of Series R Preferred stock | |
| - | | |
| - | | |
| (135,000 | ) | |
| 30,496,772 | | |
| 3,050 | | |
| 131,950 | | |
| - | | |
| - | | |
| - | | |
| - | | |
| 135,000 | |
Common
stock issued for conversion of Series S Preferred stock | |
| - | | |
| - | | |
| (10,000 | ) | |
| 2,272,728 | | |
| 227 | | |
| 9,773 | | |
| - | | |
| - | | |
| - | | |
| - | | |
| 10,000 | |
Common
stock issued for conversion of Series W Preferred stock | |
| - | | |
| - | | |
| (200,000 | ) | |
| 41,715,134 | | |
| 4,172 | | |
| 195,828 | | |
| - | | |
| - | | |
| - | | |
| - | | |
| 200,000 | |
Common
stock issued for conversion of Series Y Preferred stock | |
| - | | |
| - | | |
| (440,000 | ) | |
| 83,840,346 | | |
| 8,384 | | |
| 431,616 | | |
| - | | |
| - | | |
| - | | |
| - | | |
| 440,000 | |
Common
stock issued at fair value for services | |
| - | | |
| - | | |
| - | | |
| 45,411,996 | | |
| 4,541 | | |
| 407,613 | | |
| - | | |
| - | | |
| - | | |
| - | | |
| 412,154 | |
Common
stock issued for Series O Preferred stock dividends | |
| - | | |
| - | | |
| - | | |
| 436,819 | | |
| 44 | | |
| (44 | ) | |
| - | | |
| - | | |
| - | | |
| - | | |
| - | |
Issuances
of Series Y Preferred stock through private placement | |
| - | | |
| - | | |
| 575,100 | | |
| - | | |
| - | | |
| - | | |
| - | | |
| - | | |
| - | | |
| - | | |
| - | |
Exchange
of Series F Preferred stock for Series Q preferred stock | |
| - | | |
| - | | |
| 10,000 | | |
| - | | |
| - | | |
| - | | |
| - | | |
| - | | |
| - | | |
| - | | |
| - | |
Exchange
of Series K Preferred stock for Series W Preferred stock | |
| - | | |
| - | | |
| 10,000 | | |
| - | | |
| - | | |
| - | | |
| - | | |
| - | | |
| - | | |
| - | | |
| - | |
Issuance
of warrants | |
| - | | |
| - | | |
| - | | |
| - | | |
| - | | |
| 426,230 | | |
| - | | |
| - | | |
| - | | |
| - | | |
| 426,230 | |
Net
Loss | |
| - | | |
| - | | |
| - | | |
| - | | |
| - | | |
| - | | |
| - | | |
| - | | |
| (354,486 | ) | |
| (11,934,449 | ) | |
| (12,288,935 | ) |
Balance
at June 30, 2024 (unaudited) | |
| 31,501,000 | | |
$ | 3,150 | | |
$ | 7,307,822 | | |
| 1,613,089,087 | | |
$ | 161,309 | | |
$ | 82,490,747 | | |
$ | 100,000 | | |
$ | (132 | ) | |
$ | (2,593,979 | ) | |
$ | (131,151,184 | ) | |
$ | (50,990,089 | ) |
ORIGINCLEAR, INC. AND SUBSIDIARIES
Condensed Consolidated Statements of Cash Flows
(unaudited)
| |
Six Months Ended June 30, | |
| |
2024 | | |
2023 | |
CASH FLOWS FROM OPERATING ACTIVITIES: | |
| | |
| |
Net loss from continuing operations | |
$ | (8,423,246 | ) | |
$ | 4,668,738 | |
Net loss from assets held-for sale | |
| (3,865,689 | ) | |
| (9,271,546 | ) |
Adjustments to reconcile net loss to net cash used in operating activities: | |
| | | |
| | |
Depreciation and amortization | |
| 14,498 | | |
| 15,432 | |
Common and preferred stock issued for services | |
| 412,154 | | |
| 424,926 | |
Loss (gain) on net change in valuation of derivative liability | |
| 6,593,511 | | |
| (2,825,879 | ) |
Stock based compensation expense | |
| 169,599 | | |
| 120,540 | |
Preferred stock incentive compensation expense | |
| - | | |
| 155,852 | |
Debt discount recognized as interest expense | |
| 90,000 | | |
| - | |
Net unrealized loss on fair value of securities | |
| - | | |
| 4,521 | |
Impairment of receivable from SPAC | |
| 1,128,000 | | |
| 2,650,986 | |
Conversion and settlement value loss on WODI | |
| 1,297,000 | | |
| 6,037,589 | |
Gain on redemption of common stock | |
| (1,255,178 | ) | |
| (5,403,828 | ) |
Gain on write-off of payable | |
| (30,646 | ) | |
| - | |
Change in Assets (Increase) Decrease in: | |
| | | |
| | |
Contracts receivable | |
| 262,091 | | |
| 1,061,010 | |
Contract asset | |
| (21,804 | ) | |
| 390,206 | |
Prepaid expenses and other assets | |
| (45,401 | ) | |
| 14,226 | |
Other assets | |
| (18,000 | ) | |
| (27,694 | ) |
Change in Liabilities Increase (Decrease) in: | |
| | | |
| | |
Accounts payable | |
| 303,913 | | |
| (1,512,839 | ) |
Accrued expenses | |
| 981,394 | | |
| 401,092 | |
Contract liabilities | |
| 273,393 | | |
| (208,564 | ) |
Tax liability 83(b) | |
| - | | |
| (2,000 | ) |
Trust escrow | |
| - | | |
| 24,500 | |
Net cash used in operating activities | |
| (2,134,412 | ) | |
| (3,282,732 | ) |
| |
| | | |
| | |
CASH FLOWS USED IN INVESTING ACTIVITIES: | |
| | | |
| | |
Purchase of SPAC notes payable | |
| (1,128,000 | ) | |
| (2,650,986 | ) |
Payments received on long term asset | |
| 66,000 | | |
| 230,428 | |
Purchase of fixed assets | |
| (9,000 | ) | |
| (9,000 | ) |
Net cash used in investing activities | |
| (1,071,000 | ) | |
| (2,429,558 | ) |
| |
| | | |
| | |
CASH FLOWS FROM FINANCING ACTIVITIES: | |
| | | |
| | |
Payments on loan payable, SBA | |
| (1,327 | ) | |
| (1,273 | ) |
Proceeds from line of credit | |
| - | | |
| 200,994 | |
Payments on line of credit | |
| (125,745 | ) | |
| - | |
Proceeds from loans, merchant cash advance | |
| 135,000 | | |
| - | |
Payments on loans, merchant cash advance | |
| (189,445 | ) | |
| - | |
Equity financing through the purchase of common shares | |
| - | | |
| 168,084 | |
Net payments on cumulative preferred stock dividends | |
| 89,812 | | |
| 9,761 | |
Proceeds from convertible secured promissory notes | |
| 2,042,500 | | |
| 4,994,000 | |
Proceeds from issuance of warrants | |
| 426,230 | | |
| - | |
Net proceeds for issuance of preferred stock for cash - mezzanine classification | |
| 575,100 | | |
| 366,300 | |
Net cash provided by financing activities | |
| 2,952,125 | | |
| 5,737,866 | |
| |
| | | |
| | |
NET (DECREASE) INCREASE IN CASH AND CASH EQUIVALENTS | |
| (253,287 | ) | |
| 25,576 | |
CASH AND CASH EQUIVALENTS BEGINNING OF PERIOD | |
| 488,830 | | |
| 1,354,814 | |
CASH AND CASH EQUIVALAENTS END OF PERIOD | |
$ | 235,543 | | |
$ | 1,380,390 | |
| |
| | | |
| | |
SUPPLEMENTAL DISCLOSURES OF CASH FLOW INFORMATION | |
| | | |
| | |
Interest and dividends paid | |
$ | 28,817 | | |
$ | 255,983 | |
Taxes paid | |
$ | - | | |
$ | - | |
| |
| | | |
| | |
SUPPLEMENTAL DISCLOSURES OF NON CASH TRANSACTIONS | |
| | | |
| | |
Common stock issued at fair value for conversion of debt, plus accrued interest, and other fees | |
$ | - | | |
$ | 167,365 | |
Issuance of Series O dividends | |
$ | 44 | | |
$ | 50 | |
Preferred stock converted to common stock - mezzanine | |
$ | 810,000 | | |
$ | 2,510,000 | |
Exchange of Series R Preferred Stock for WODI secured convertible note | |
$ | - | | |
$ | 100,000 | |
Exchange from liability to mezzanine | |
$ | 20,000 | | |
$ | - | |
Common stock issued as settlement | |
$ | 12,221 | | |
$ | 26,518 | |
Exchange of Series X Preferred Stock for WODI secured convertible note | |
$ | - | | |
$ | 250,000 | |
Shares issued for alternate vesting | |
$ | - | | |
$ | 1,158 | |
Redemption of shares for secured promissory notes | |
$ | - | | |
$ | 58,925 | |
Conversion of liability classified preferred stock to mezzanine | |
$ | - | | |
$ | 100,000 | |
ORIGINCLEAR, INC.
AND SUBSIDIARIES
Notes to Consolidated
Financial Statements
(unaudited)
The accompanying unaudited condensed
consolidated financial statements of OriginClear, Inc. (the “Company”) are unaudited and, in the opinion of management, include
all adjustments, including all normal recurring items for a fair statement of the Company’s financial position and results of operations
for all periods presented. All intercompany balances and transactions are eliminated in consolidation.
The consolidated financial statements
should be read in conjunction with the consolidated financial statements and notes thereto included in the Company’s Form 10-K for
the fiscal year ended December 31, 2023 (the Annual Report). The accompanying unaudited consolidated financial statements and related
notes have been prepared in accordance with generally accepted accounting principles (“GAAP”) in the United States for interim
financial information and with the instructions to Form 10-Q and Rule 10-01 of regulation S-X. Accordingly, they do not include all of
the information and footnotes required by GAAP for complete financial statements.
The consolidated financial statements
included in this report have been prepared consistently with the accounting policies described in the Annual Report, except as noted,
and should be read together with the Annual Report.
The results of operations for the three
and six months ended June 30, 2024 are not necessarily indicative of the results to be expected for fiscal year ending December 31, 2024.
OriginClear
was founded as OriginOil® in 2007 and began trading on the OTC in 2008. In 2015, it was renamed OriginClear® to reflect its new
mission to develop breakthrough businesses in the industrial water sector. Today, OriginClear is structured as the Clean Water Innovation
Hub™ and intends to leverage its retail investor development capabilities to help bring potentially disruptive companies to market.
For the foreseeable future, OriginClear will focus its entire capabilities to the success of its subsidiary, Water On Demand, Inc. (“WODI”).
In 2023,
OriginClear combined three of its operating divisions into WODI in anticipation of a merger of such subsidiary with Fortune Rise Acquisition
Corp (“FRLA”) a Special Purpose Acquisition Company. The definitive merger agreement between WODI and FRLA was announced
on October 24, 2023: https://www.originclear.com/company-news/originclears-water-on-demand-and-fortune-rise-acquisition-corporation-announce-business-combination-to-create-nasdaq-listed-company.
WODI is now
composed of three operating units: Modular Water Systems (“MWS”), Progressive Water Treatment (“PWT”), and Water
on Demand (“WOD”), the last being a development stage business.
|
● |
PWT is responsible
for a significant percentage of the Company’s revenue, specializing in engineered water treatment solutions and custom treatment
systems. |
|
● |
MWS holds a worldwide,
exclusive master license to the intellectual property of Daniel M. Early, which includes five patents and related intellectual property,
know-how, and trade secrets (“Early IP”). In April 2023, OriginClear commissioned a valuation of the Early IP. MWS features
products differentiated by the Early IP and complemented with additional know-how and trade secrets. |
|
● |
WOD is an incubation
of the Company that aims to offer private businesses water self-sustainability as a service, enabling them to pay for water treatment
and purification services on a per-gallon basis. This model is commonly known as Design-Build-Own-Operate (“DBOO”). |
Going Concern
The accompanying financial statements
have been prepared on a going concern basis of accounting, which contemplates continuity of operations, realization of assets and liabilities
and commitments in the normal course of business. These financial statements do not reflect any adjustments that might result if the
Company is unable to continue as a going concern. These factors, among others, raise substantial doubt about the Company’s
ability to continue as a going concern. Our independent auditors, in their report on our audited financial statements for the year ended
December 31, 2023, expressed substantial doubt about our ability to continue as a going concern.
The Company’s ability to continue
as a going concern and appropriateness of using the going concern basis depend on, among other things, achieving profitable operations
and receiving additional cash infusions. During the six months ended June 30, 2024, the Company obtained funds from the issuance
of convertible note agreements and from sale of its preferred stock. Management believes this funding will continue from its’ current
investors and from new investors. The Company generated revenue of $6,573 and its operating divisions have standing purchase orders and
open invoices with customers, which will provide funds for operations.
Management believes the existing shareholders,
the prospective new investors, and future sales will provide the additional cash needed to meet the Company’s obligations as they
become due and will allow the development of its core business operations. However, no assurance can be given that any future financing
will be available or, if available, that it will be on terms that are satisfactory to the Company. Even if the Company is able to obtain
additional financing, it may contain restrictions on our operations in the case of debt financing or cause substantial dilution for our
stockholders in the case of equity financing.
| 2. | Summary of Significant
Accounting Policies |
This summary of significant accounting
policies is presented to assist in understanding the Company’s consolidated financial statements. The consolidated financial statements
and notes are representations of the Company’s management, which is responsible for their integrity and objectivity. These accounting
policies conform to GAAP and have been consistently applied in the preparation of the consolidated financial statements.
Principles of Consolidation
The accompanying consolidated financial
statements include the accounts of OriginClear, Inc. and its subsidiaries: WODI, (which consists of operating divisions Progressive Water
Treatment, Modular Water Systems and Water On Demand), Water On Demand #1, Inc., and OriginClear Technologies, Ltd. All material intercompany
transactions have been eliminated upon consolidation of these entities.
Cash and Cash Equivalent
The Company considers all highly liquid
investments with an original maturity of three months or less to be cash equivalents.
Use of Estimates
The preparation of financial statements
in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities,
the disclosure of contingent assets and liabilities at the date of the financial statements, and the reported amounts of revenues and
expenses during the reporting period. Actual results could differ from those estimates. Significant estimates include, but are not limited
to, impairments and estimations of long-lived assets, revenue recognition on percentage of completion type contracts, allowances for
uncollectible accounts, warranty reserves, inventory valuation, derivative liabilities and other conversion features, fair value investments,
valuations of non-cash capital stock issuances and the valuation allowance on deferred tax assets. The Company bases its estimates on
historical experience and on various other assumptions that are believed to be reasonable under the circumstances, the results of which
form the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources.
Actual results may differ from these estimates under different assumptions or conditions.
Net Earnings (Loss) per Share Calculations
Basic loss per share is calculated
by dividing net income (loss) available to common shareholders by the weighted-average number of common shares outstanding during the
period. Diluted earnings per share is calculated similarly to basic earnings per share, except that the denominator is adjusted to include
securities or other contracts to issue common stock that would have been outstanding if the potential common shares had been issued and
if the additional common shares were dilutive. For the six months ended June 30, 2024, and 2023, the Company’s diluted earnings
per share were the same as basic loss per share because the inclusion of any potential common shares would have been anti-dilutive due
to the Company’s net losses.
The Company excludes issuable shares
from warrants, convertible notes, and preferred stock, if their impact on the loss per share is anti-dilutive, and includes the issuable
shares if their impact is dilutive.
Loss per share
| |
For the Six Months Ended | |
| |
June 30, | |
| |
2024 | | |
2023 | |
Loss to common shareholders (Numerator)- continuing operations | |
$ | (8,423,246 | ) | |
$ | 4,668,738 | |
Loss to common shareholders (Numerator) - related to assets held-for-sale | |
| (3,865,689 | ) | |
| (9,271,546 | ) |
Basic and diluted weighted average number of common shares outstanding (Denominator) | |
| 1,501,184,304 | | |
| 1,243,518,367 | |
The Company excludes issuable shares
from warrants, convertible notes and preferred stock, if their impact on the loss per share is anti-dilutive and includes the issuable
shares if their impact is dilutive.
Revenue Recognition
We recognize revenue in accordance
with Accounting Standards Codification (“ASC”) ASC 606, Revenue from Contract with Customers (“ASC 606”). We
recognize revenue when services are performed, and at the time of shipment of products, provided that evidence of an arrangement exists,
title and risk of loss have passed to the customer, fees are fixed or determinable, and collection of the related receivable is reasonably
assured.
Nature of Contracts and Performance
Obligations
Engineered Water Treatment Solutions
(PWT)
We design, manufacture, and install
our customer water treatment systems for municipalities, industrial clients, and commercial entities. Our performance obligations typically
include the delivery and installation of water treatment systems that meet specific customer requirements. Revenue from these contracts
is recognized over time as performance obligations are satisfied, using a cost-cost input method, which reflects the extent of progress
towards completion. The transaction price is determined based on fixed fees agreed upon in the contract, and any variable considerations,
such as performance bonuses, are estimated at contract inception and constrained to avoid significant reversals.
Sales Price Calculation
The transaction price for each contract
is determined based on the agreed-upon terms with the customer, indicating fixed fees and variable consideration where applicable. Variable
consideration is estimated at contract inception and constrained to the extent that is it probable that significant reversal of recognized
revenue will not occur when the uncertainty is resolved.
Contract Modifications
Contract modifications are accounted
for when they create or change existing enforceable rights and obligations. The impact of modifications on transaction prices and performance
obligations is recognized in the period when the modifications are approved.
Significant Judgements and Estimates
| ● | Estimating
Progress Towards Completion: For long-term contracts, we use the cost-to-cost method to estimate
progress towards completion, considering total costs incurred relative to total estimated
costs to complete the project. |
| ● | Variable
Consideration: Estimates to variable considerations are constrained to ensure that recognized
revenue is not subject to significant reversals in future periods. |
Material Rights and Obligations
Our contracts may include material
rights for customers to receive effective water treatment solutions and ongoing maintenance services. Our obligations include designing,
manufacturing, delivering, installing, and maintaining water treatment systems, as well as providing continuous water treatment services
under the DBOO model.
In accordance with ASC 280-10-50-38
through 50-41, we provide entity wide disclosures, including:
| ● | Product
and Services: Our products and service offering include comprehensive water treatment solutions,
such as design, manufacturing, and outsourced water treatment services. |
| ● | Geographical
Areas: We primarily serve customers in the United States and Canada, with some international
clients in Japan, Argentina and the Middle East. |
Significant Customers
Revisions in cost and profit estimates
during the course of the contract are reflected in the accounting period in which the facts for the revisions become known. Provisions
are estimated losses on uncompleted contracts are made in the period in which such losses are determined. Changes in job performance,
job conditions, and estimated profitability, including those arising from contract penalty provisions, and final contract settlements,
may result in revisions to costs and income which are recognized in the period the revisions are determined.
Contract receivables are recorded
on contracts for amounts currently due based on progress billings, as well as retention, which are collectible upon completion of the
contracts. Accounts payable to material suppliers and subcontractors are recorded for amounts currently due based upon work completed
or materials received, as are retention due subcontractors, which are payable upon completion of the contract. General and administrative
expenses are charged to operations and not allocated to contract costs.
We recognize revenue when services
are performed, and at the time of shipment of products, provided that evidence of an arrangement exists, title and risk of loss have
passed to the customer, fees are fixed or determinable, and collection of the related receivable is reasonably assured.
Revenues and related costs on construction
contracts are recognized as the performance obligations for work are satisfied over time in accordance with ASC 606. Under ASC 606, revenue
and associated profit will be recognized as the customer obtains control of the goods and services promised in the contract (i.e., performance
obligations). All un-allocable indirect costs and corporate general and administrative costs are charged to the periods as incurred.
However, in the event a loss on a contract is foreseen, the Company will recognize the loss as it is determined.
Revisions in cost and profit estimates
during the course of the contract are reflected in the accounting period in which the facts for the revisions become known. Provisions
for estimated losses on uncompleted contracts are made in the period in which such losses are determined. Changes in job performance,
job conditions, and estimated profitability, including those arising from contract penalty provisions, and final contract settlements,
may result in revisions to costs and income, which are recognized in the period the revisions are determined.
Contract receivables are recorded
on contracts for amounts currently due based upon progress billings, as well as retention, which are collectible upon completion of the
contracts. Accounts payable to material suppliers and subcontractors are recorded for amounts currently due based upon work completed
or materials received, as are retention due subcontractors, which are payable upon completion of the contract. General and administrative
expenses are charged to operations as incurred and are not allocated to contract costs.
Contract Receivable
The Company bills its customers in
accordance with contractual agreements, which generally require billing on a progressive basis as work is completed. Credit is extended
based on evaluation of each client’s financial condition, and collateral is not required. The Company maintains an allowance for
doubtful accounts for estimated losses that may arise if any customer is unable to make required payments.
Management performs a quantitative
and qualitative review of past-due receivables from customers on a monthly basis. An allowance against uncollectible items is recorded
for each customer after all reasonable means of collection have been exhausted, and the potential for recovery is considered remote.
Reasonable means of collection may include multiple follow-up communications, renegotiation of payment terms, and if necessary, legal
action.
The allowance for doubtful accounts
was $355,453 and $379,335 as of June 30, 2024, and December 31, 2023, respectively. The net contract receivable balance was $1,247,416
and $1,509,504 as of June 30, 2024, and December 31, 2023, respectively.
Indefinite Lived Intangibles and
Goodwill Assets
The Company accounts for business
combinations under the acquisition method of accounting in accordance with ASC 805, “Business Combinations.” Under this method,
total purchase price is allocated to the tangible and identified intangible assets acquired and liabilities assumed based on their estimated
fair values. The purchase price allocation uses the information currently available, and may be adjusted, up to one year from acquisition
date, after obtaining more information regarding, among other things, asset valuations, liabilities assumed and revisions to preliminary
estimates. The purchase price in excess of the fair value of the tangible and identified intangible assets acquired less liabilities
assumed, is recognized as goodwill.
The Company tests for indefinite lived
intangibles and goodwill impairment in the fourth quarter of each year, or whenever events or circumstances indicate that the carrying
amount of the asset exceeds its fair value and may not be recoverable. In accordance with its policies, the Company performed a qualitative
assessment of indefinite lived intangibles and goodwill as of June 30, 2024, and 2023, respectively, and determined there was no impairment
of indefinite lived intangibles and goodwill.
Prepaid Expenses
The Company records expenditures that
have been paid in advance for goods or services to be received in the future as prepaid expenses. These prepaid expenses are initially
recorded as assets because they have future economic benefits. They are expensed as the benefits are realized.
The prepaid expenses balance was $45,401
and $0 as of June 30, 2024, and December 31, 2023, respectively.
Property and Equipment
Property and equipment are stated at
cost. Gain or loss is recognized upon disposal of property and equipment, and the asset and related accumulated depreciation are removed
from the accounts. Expenditures for maintenance and repairs are charged to expense as incurred, while expenditures for addition and improvement
are capitalized. Furniture and equipment are depreciated on the straight-line method and include the following categories:
Estimated Life | |
|
Machinery and equipment | |
5-10 years |
Furniture, fixtures and computer equipment | |
3-7 years |
Computer software | |
3 years |
Vehicles | |
3-6 years |
Leasehold improvements | |
2-5 years or lease term |
| |
June 30, | | |
December 31, | |
| |
2024 | | |
2023 | |
Machinery and equipment | |
$ | 383,571 | | |
$ | 383,569 | |
Computer equipment and software | |
| 66,491 | | |
| 66,493 | |
Vehicles | |
| 64,277 | | |
| 64,276 | |
Demo Units | |
| 36,139 | | |
| 36,139 | |
Furniture and fixtures | |
| 29,809 | | |
| 29,810 | |
Leasehold improvements | |
| 26,725 | | |
| 26,725 | |
Gross property and equipment | |
| 607,012 | | |
| 607,012 | |
Less accumulated depreciation | |
| (474,774 | ) | |
| (460,276 | ) |
Net property and equipment | |
$ | 132,238 | | |
$ | 146,736 | |
Long-lived assets held and used by
the Company are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may
not be recoverable. If the event that the facts and circumstances indicate that the cost of any long-lived assets be impaired, an evaluation
of recoverability would be performed in accordance with GAAP.
Depreciation expense during the six
months ended June 30, 2024, and 2023, was $14,498 and $15,432, respectively.
Long Term Asset Held for Sale
On March 1, 2021, the Company
issued 630 shares of Series T Preferred Stock to an accredited investor (the “Purchaser’’) per the terms of a
Securities Purchase Agreement (the “SPA”). According to the SPA, the Purchaser received 630 shares of Series T
Preferred Stock, and two-year cashless warrants to acquire 25,200,000 shares of the Company’s common stock, valued
at $0.05 per share. These warrants are exercisable at any time, in whole or in part. In lieu of the purchase price for the
Series T Preferred Stock, the Purchaser transferred to the Company real property with an aggregate value of $630,000. This property,
based on a independent appraisal, consisted of residential real estate in Buenos Aires, Argentina, valued at $580,000, and eight
undeveloped lots in the Terralta private neighborhood development, valued at $50,000. The property was recorded on the condensed
consolidated balance sheet as long-term asset held for sale at $630,000. The
property was listed for sale in July 2021. Due to impairment indicators during the year ended December 31, 2021, the Company
reduced the value of the asset from $630,000 to $514,000, recording an impairment of $116,000 in the consolidated financial
statements.
During the year ended December 31,
2022, after evaluating several offers, the Company accepted an offer of $400,000, which was $114,000 below the adjusted value, reflecting
the real estate market conditions in Buenos Aires, Argentina. Based on that indicator of impairment, during the year ended December 31,
2022, the Company further adjusted the value of the asset held for sale from $514,000 to $400,000 on the balance sheet and recorded an
impairment of $114,000 in the consolidated financial statements. All Series T preferred stock was converted, and the related warrants
expired by during the period ended December 31, 2022.
In January 2023, the Company accepted
the offer and on April 8, 2023, executed a deed for the sale of the property for $400,000. The payment terms included an initial payment
of $235,000, with the remaining $165,000 to be paid over fifteen monthly installments of $11,000 each.
The initial payment was received by
SMS Argentina (“SMS”), an accounting and consulting firm that was appointed by the Company as the Power of Attorney for the
property. SMS remitted taxes due on the transaction to the Federal Administration of Public Income (“AFIP”), the taxation
authority in Argentina. On June 21, 2023, the Company received a net payment of $164,935, after taxes and closing fees totaling $65,493.
During 2023, the Company recorded a
receivable of $169,572 for the remaining amount on the consolidated financial statements. As of June 30, 2024, the balance of the receivable
was $33,000 which is reflected on the condensed consolidated balance sheet.
Stock-Based Compensation
The Company periodically issues stock
options and warrants to employees and non-employees in non-capital raising transactions for services and for financing costs. The Company
accounts for stock option and warrant grants issued and vesting to employees based on the authoritative guidance provided by the Financial
Accounting Standards Board (“FASB”), where the value of the award is measured on the grant date and recognized over the vesting
period.
For stock option and warrant grants
issued and vesting to non-employees, the Company follows the authoritative guidance of the FASB, where the value of the stock compensation
is determined based upon the measurement date, which is either (a) the date at which a performance commitment is reached, or (b) the
date at which the necessary performance to earn the equity instruments is complete. Non-employee stock-based compensation charges are
generally amortized over the vesting period on a straight-line basis. If there are no future performance requirements by the non-employee,
option grants vest immediately, and the total stock-based compensation charge is recorded in the period of the measurement date.
Accounting for Derivatives
The Company evaluates all its financial
instruments to determine if they qualify as derivatives or contain features that qualify as embedded derivatives. For derivative financial
instruments accounted for as liabilities, the derivative instrument is initially recorded at its fair value and revalued at each reporting
date. Changes in the fair value are reported in the consolidated statements of operations.
For stock-based derivative financial
instruments, the Company uses a probability-weighted average series Binomial lattice option pricing model to value the derivative instruments
at inception and on subsequent valuation dates.
The classification of derivative instruments,
including the determination of whether they should be recorded as liabilities or as equity, is evaluated at the end of each reporting
period. Derivative instrument liabilities are classified on the condensed consolidated balance sheet as current or non-current based
on whether or not the net-cash settlement of the derivative instrument could be required within 12 months of the balance sheet date.
Fair Value of Financial Instruments
Fair Value of Financial Instruments
requires disclosure of the fair value information, whether or not recognized in the condensed consolidated balance sheet, where it is
practicable to estimate that value. As of June 30, 2024, the balances reported for cash, contract receivables, costs in excess of billing,
prepaid expenses, accounts payable, billing in excess of cost, and accrued expenses approximate the fair value due to their short maturities.
We adopted ASC Topic 820 for financial
instruments measured as fair value on a recurring basis. ASC Topic 820 defines fair value, established a framework for measuring fair
value in accordance with GAAP, and expands disclosures about fair value measurements.
Fair value is defined as the price
that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the
measurement date. ASC Topic 820 established a three-tier fair value hierarchy which prioritizes the inputs used in measuring fair value.
The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (level 1 measurements)
and the lowest priority to unobservable inputs (level 3 measurements). These tiers include:
|
● |
Level 1: Observable inputs
such as quoted prices for identical instruments in active markets; |
|
|
|
|
● |
Level 2: Inputs other than
quoted prices in active markets that are either directly or indirectly observable, such as quoted prices for similar instruments
in active markets or quoted prices for identical or similar instruments in markets that are not active. |
|
|
|
|
● |
Level 3: Unobservable inputs
in which little or no market data exists, therefore requiring an entity to develop its own assumptions, such as valuations derived
from valuation techniques in which one or more significant inputs or significant value drivers are unobservable. |
The following table presents certain
investments and liabilities of the Company’s financial assets measured and recorded at fair value on the Company’s balance
sheets on a recurring basis and their level within the fair value hierarchy as of June 30, 2024:
| |
Total | | |
(Level 1) | | |
(Level 2) | | |
(Level 3) | |
Investment at fair value-securities, June 30, 2024 | |
$ | 39,367 | | |
$ | 39,367 | | |
$ | - | | |
$ | - | |
| |
Total | | |
(Level 1) | | |
(Level 2) | | |
(Level 3) | |
Convertible notes liability | |
$ | 14,101,479 | | |
$ | - | | |
$ | - | | |
$ | 14,101,479 | |
Warrants liability | |
| 234,791 | | |
| - | | |
| - | | |
| 234,791 | |
Total derivative liability, June 30, 2024 | |
| 14,336,270 | | |
| - | | |
| - | | |
| 14,336,270 | |
The following is a reconciliation
of the derivative liability for which level 3 inputs were used in determining the approximate fair value:
Balance as of January 1, 2024 | |
$ | 7,742,759 | |
Net loss on conversion of debt and change in derivative liabilities | |
| 6,593,511 | |
Balance as of June 30, 2024 | |
$ | 14,336,270 | |
For the purpose of determining the
fair market value of the derivative liability, the Company used a Binomial lattice formula valuation model. The significant assumptions
used in the Binomial lattice formula valuation of the derivative are as follows:
| |
| June
30, | |
| |
| 2024 | |
Risk free interest rate | |
| 4.53% - 5.01% | |
Stock volatility factor | |
| 101.9% - 218.8% | |
Weighted average expected option life (in years) | |
| .5 - 4.5 | |
Expected dividend yield | |
| None | |
Segment Reporting
The Company operates in a single business
segment based on its organizational structure and the manner in which the operations are managed and evaluated.
Marketable Securities
The Company adopted ASU 2016-01, “Financial
Instruments – Recognition and Measurement of Financial Assets and Financial Liabilities.” ASU 2016-01 requires investments,
except those accounted for under the equity method of accounting, or those that result in consolidation of the investee, to be measured
at fair value, with changes in fair value recognized in net income. It also mandates the use the exit price notion for measuring the
fair value of financial instruments for disclosure purposes and requires the separate presentation of financial assets and financial
liabilities by measurement category and form of financial asset. Additionally, it eliminates the requirement for public business entities
to disclose the method(s) and significant assumptions used to estimate the fair value of financial instruments measured at amortized
cost.
The Company evaluated the impact of
this standard on the condensed consolidated financial statements and determined it had a significant impact. The Company accounts for
its investment in Water Technologies International, Inc. as available-for-sale securities, with unrealized gains on these securities
recognized in net income.
Licensing agreement
The Company analyzed the licensing
agreement using ASU 606 to determine the timing of revenue recognition. The licensing of intellectual property (“IP”) is
distinct from the non-license goods or services and possesses significant standalone functionality that provides a benefit or value to
the customer. This functionality does not change during the license period due to the licensor’s activities. Because the significant
standalone functionality is delivered immediately, revenue is generally recognized when the license is delivered.
Reclassification
Certain amounts in the prior period
financial statements have been reclassified to conform to the presentation used in the current condensed consolidated financial statements
for comparative purposes. These reclassifications had no material effect on the Company’s previously issued financial statements.
Work-in-Process
The Company recognizes as an asset
the accumulated costs for work-in-process on projects expected to be delivered to customers. Work-in-process includes the cost of materials
and labor related to the construction of equipment to be sold to customers.
Recently Issued Accounting Pronouncements
Management has reviewed recently issued
pronouncements and does not believe that any other recently issued, but not yet effective, accounting standards, if currently adopted,
would have a material effect on the accompanying condensed financial statements.
| 3. | WODI Assets
and Liabilities Held-for-Sale, Discontinuing Operations |
On September
21, 2023, WODI entered into a merger agreement with PWT, whereby WODI was merged with PWT. This merger was completed to create better
enterprise value for a potential merger opportunity with FRLA. In connection with the merger, PWT changed its name to Water on Demand,
Inc.
On September
28, 2023, the Letter of Intent (“LOI”) executed on January 5, 2023, with WODI was amended to designate PWT as the
new target of the acquisition. Under the amended LOI, FRLA proposed to acquire all the outstanding securities of the new combined WODI/PWT
entity, based on certain material financial and business terms and conditions being met. The LOI is not binding on the parties and is
intended solely to guide good-faith negotiations toward definitive agreements.
On October
24, 2023, FRLA and WODI entered into a definitive business combination agreement (the “BCA”). The transaction represents
a pro forma equity valuation of approximately $72 million for the combined company, assuming no further redemptions of FRLA public shares
by FRLA’s public shareholders.
On October 25, 2023, at the Special
Meeting, FRLA shareholders approved a proposal to extend the period FRLA has to consummate its initial business combination by up to
twelve-one-month extensions, from November 5, 2023, to November 5, 2024, subject to certain conditions.
On February 14, 2024, the Company
and FRLA filed a registration statement on Form S-4 with the SEC which includes a preliminary proxy statement and prospectus in connection
with the proposed business combination with WODI.
In accordance
with ASC 205-20, a disposal of a component or a group of components should be reported in discontinued operations if the disposal represents
a strategic shift that has (or will have) a major effect on an entity’s operations and financial results when a component of or
group of components meets the initial criteria for classification of held for sale to be classified as held for sale. Per the initial
criteria for classification of held for sale, a component or a group of components, or a business or nonprofit activity (the entity to
be sold), should be classified as held for sale in the period in which all of the following criteria are met:
|
● |
Management, having the
authority to approve the action, commits to a plan to sell the entity to be sold. |
|
● |
The entity to be sold is
available for immediate sale in its present condition subject only to terms that are usual and customary for sales of such entities
to be sold. |
|
● |
An active program to locate
a buyer or buyers and other actions required to complete the plan to sell the entity to be sold have been initiated. |
|
● |
The sale of the entity
to be sold is probable (the future event or events are likely to occur), and transfer of the entity to be sold is expected to qualify
for recognition as a completed sale, within one year, unless events or circumstances beyond an entity’s control extend the
period required to complete the sale as discussed below. |
|
● |
The entity to be sold is
being actively marketed for sale at a price that is reasonable in relation to its current fair value. |
|
● |
Actions required to complete
the plan indicate that it is unlikely that significant changes to the plan will be made or that the plan will be withdrawn. |
Since the proposed business combination
of WODI with FRLA meets all the initial criteria for classification of held for sale, the assets, liabilities, and operating results
of WODI have been classified as held for sale in the period ending June 30, 2024. The condensed consolidated financial statements for
the prior year ending in December 31, 2023, have been adjusted to reflect comparable information as follows:
Assets and Liabilities Held-For-Sale
| | June 30, | | | December 31, | |
| | 2024 | | | 2023 | |
CURRENT ASSETS | | | | | | |
Cash | | $ | 202,644 | | | $ | 374,192 | |
Contracts receivable, net allowance of $355,453 and $379,335, respectively (Note 2) | | | 1,247,416 | | | | 1,509,504 | |
Contract assets (Note 7) | | | 476,906 | | | | 455,102 | |
Prepaid expenses | | | 34,354 | | | | - | |
Total Current Assets Held-For-Sale | | | 1,961,320 | | | | 2,338,798 | |
| | | | | | | | |
NET PROPERTY AND EQUIPMENT HELD-FOR-SALE | | | 2,006 | | | | 3,370 | |
| | | | | | | | |
NON-CURRENT ASSETS HELD-FOR SALE | | | | | | | | |
SPAC Class B common shares purchase cost (Note 10) | | | 400,000 | | | | 400,000 | |
Security deposit | | | 18,000 | | | | - | |
| | | 418,000 | | | | 400,000 | |
CURRENT LIABILITIES HELD-FOR-SALE | | | | | | | | |
Accounts payable and other payable | | $ | 1,459,460 | | | $ | 1,335,211 | |
Accrued expenses | | | 1,992,046 | | | | 1,103,159 | |
Contract liabilities (Note 7) | | | 1,619,759 | | | | 1,346,366 | |
Tax liability 83(b) | | | 13,600 | | | | 13,600 | |
Customer deposit | | | 143,503 | | | | 143,503 | |
Warranty reserve | | | 20,000 | | | | 20,000 | |
Line of credit (Note 11) | | | 53,063 | | | | 178,808 | |
Secured loans payable | | | 146,250 | | | | 110,695 | |
Convertible secured promissory notes (Note 6) | | | 20,068,589 | | | | 16,729,089 | |
Total Current Liabilities Held-For-Sale | | $ | 25,516,270 | | | $ | 20,980,431 | |
Net Loss from Assets Held-For-Sale
| |
Six Months Ended
June 30 | |
| |
2024 | | |
2023 | |
| |
| | |
| |
Sales | |
$ | 2,604,196 | | |
$ | 3,823,932 | |
Cost of goods sold | |
| 2,332,346 | | |
| 3,513,086 | |
Gross Profit | |
| 271,850 | | |
| 310,846 | |
| |
| | | |
| | |
Operating Expenses | |
| | | |
| | |
Selling and marketing expenses | |
| 94,671 | | |
| 42,988 | |
General and administrative expenses | |
| 578,784 | | |
| 560,247 | |
Total Operating Expenses | |
| 673,455 | | |
| 603,235 | |
| |
| | | |
| | |
Loss from Operations | |
| (401,605 | ) | |
| (292,389 | ) |
| |
| | | |
| | |
OTHER INCOME (EXPENSE) | |
| | | |
| | |
Other income | |
| 1,143 | | |
| 126,879 | |
Impairment of receivable from SPAC | |
| (1,128,000 | ) | |
| (2,600,985 | ) |
Conversion and settlement value added to note purchase
agreements (see Note 6) | |
| (1,297,000 | ) | |
| (6,037,589 | ) |
Preferred stock compensation expense | |
| - | | |
| (155,852 | ) |
Interest expense | |
| (1,040,227 | ) | |
| (311,610 | ) |
TOTAL OTHER (EXPENSE) INCOME | |
| (3,464,084 | ) | |
| (8,979,157 | ) |
| |
| | | |
| | |
NET LOSS FROM ASSETS-HELD-FOR-SALE | |
$ | (3,865,689 | ) | |
$ | (9,271,546 | ) |
OriginClear, Inc. Preferred Stock
Series C
On March 14, 2017, the Board of Directors
authorized the issuance of 1,000 shares of Series C preferred stock, par value $0.0001 per share, to T. Riggs Eckelberry in exchange
for his continued employment with the Company. The holder of Series C preferred stock is not entitled to receive dividends, has no liquidation
preference, and the shares do not have any conversion rights. The Series C Preferred Stock entitles the holder to 51% of the total voting
power of the stockholders. The purchase price of the Series C preferred stock was $0.0001 per share, representing a total purchase price
of $0.10 for 1,000 shares. As of June 30, 2024, there were 1,000 shares of Series C preferred stock outstanding held by Mr. Eckelberry.
Series D-1
On April 13, 2018, the Company designated
50,000,000 shares of its authorized preferred stock as Series D-1 preferred stock. The shares of Series D-1 preferred stock are not entitled
to dividends and do not have a liquidation preference. Each share of Series D-1 preferred stock is convertible into 0.0005 of one share
of common stock. The Series D-1 preferred stock may not be converted to common stock to the extent such conversion would result in the
holder beneficially owning more than 4.99% of outstanding common stock, which may be increased to 9.99% at the holder’s discretion
upon 61 days’ written notice. As of June 30, 2024, there were 31,500,000 shares of Series D-1 preferred stock issued and outstanding.
Series F
On August 14, 2018, the Company designated
6,000 shares as Series F preferred stock. The shares of Series F preferred stock have a liquidation preference equal to the stated value
of $1,000 per share plus any accrued but unpaid dividends. The Series F preferred stock is not convertible into common stock. The holders
of Series F preferred stock are entitled to quarterly dividends at the annual rate of 8% of the stated value, in preference to any dividends
on the common stock. The shares do not carry any voting rights.
The Company may, in its sole discretion,
redeem all or any portion of the outstanding Series preferred stock at a price equal to the stated value plus any accrued but unpaid
dividends. The Company was required to redeem all outstanding shares of Series F preferred stock on September 1, 2020. During the six
months ended June 30, 2024, the Company exchanged an aggregate of 10 shares of Series F preferred stock for 10 shares
of Series Q preferred stock. No gain or loss was recognized in the exchange.
As of June 30, 2024, the Company had
50 outstanding shares of Series F preferred stock, which the Company was required to, and failed to, redeem on September 1, 2020, and
remains in default for an aggregate redemption price (equal to the stated value) of $50,000.
Series G
On January 16, 2019, the Company designated 6,000 shares
as Series G preferred stock, each share having a stated value of $1,000. Holders of Series G preferred stock are entitled to cumulative
dividends at the annual rate of 8% of the stated value, payable quarterly. The Series G preferred stock does not have voting rights,
except as required by law and is not convertible into common stock.
The Company may, at its sole discretion,
redeem all or any portion of the outstanding Series G preferred stock at a price equal to the stated value plus any accrued but unpaid
dividends. The Company was required to redeem such shares of Series G preferred stock on April 30, 2021. Pursuant to certain subscription
agreements entered into with purchasers of the Series G preferred stock, each purchaser received shares of the Company’s common
stock equal to an amount of, for each share of Series G preferred stock purchased, five hundred dollars ($500) divided by the closing
price on the date the Company receives the executed subscription documents and purchase price from such investor.
As of June 30, 2024, there were 25 shares
of Series G preferred stock issued and outstanding, which the Company was required to, and failed to redeem on April 30, 2021, for an
aggregate redemption price (equal to the stated value) of $25,000.
Series I
On April 3, 2019, the Company designated 4,000 shares
of preferred stock as Series I with a stated value of $1,000 per share. Series I holders are entitled to cumulative dividends at
the annual rate of 8% of the stated value, payable quarterly within 60 days from the end of each fiscal quarter. The Series I preferred
stock is not entitled to any voting rights except as may be required by applicable law, and are not convertible into common stock.
The Company has the right to redeem
the Series I preferred stock at any time at a price equal to the stated value plus any accrued but unpaid dividends. The Company is required
to redeem the Series I preferred stock two years following the date that is the later of the (i) final closing of the tranche (as designated
in the applicable subscription agreement) or (ii) the expiration date of the tranche that such shares to be redeemed were a part of. The
Company was required to redeem such shares of Series I between May 2, 2021, and June 10, 2021, at a price equal to the stated value plus
any accrued but unpaid dividends.
The issuances of the shares were accounted
for under ASC 480-10-25-4, which requires liability treatment for certain mandatorily redeemable financial instruments, and the cumulative
dividends are recorded as interest expense. As of June 30, 2024, there were 25 shares of Series I preferred stock issued and
outstanding which the Company was required to, and failed to redeem by June 10, 2021, and was and remains in default for an aggregate
redemption price (equal to the stated value) of $25,000.
Series J
On April 3, 2019, the Company designated 100,000 shares
of preferred stock as Series J, with a stated value of $1,000 per share. Holders of Series J preferred stock are entitled to receive
dividends on an as-converted basis with the Company’s common stock. The Series J preferred stock is convertible into shares of
the Company’s common stock, on the terms and conditions set forth in the Series J Certificate of Designation (“COD”),
which includes certain make-good shares for certain prior investors. As of June 30, 2024, there were 210 shares of Series J
preferred stock issued and outstanding.
Series K
On June 3, 2019, the Company designated 4,000 shares
of preferred stock as Series K, with a stated value of $1,000 per share. Series K holders are entitled to cumulative dividends at the
annual rate of 8% of the stated value, payable quarterly within 60 days from the end of each fiscal quarter. The Series K preferred
stock is not entitled to voting rights except as required by law and is not convertible into common stock.
The Company has the right to redeem
the Series K preferred stock at any time at a price equal to the stated value plus any accrued but unpaid dividends. The Company was
required to redeem the Series K shares two years following the date that is the later of the (i) final closing of the tranche (as designated
in the applicable subscription agreement) or (ii) the expiration date of the tranche that such shares to be redeemed were a part of.
The Company was required to redeem such shares of Series K between August 5, 2021 and April 24, 2022, at a price equal to the stated
value plus any accrued but unpaid dividends.
The issuance of the shares was accounted
for under ASC 480-10-25-4, which requires liability treatment for certain mandatorily redeemable financial instruments, and the cumulative
dividends are recorded as interest expense. During the six months ended June 30, 2024, the Company exchanged an aggregate of 10 shares
of Series K preferred stock for 10 shares of Series W preferred stock. No gain or loss was recognized.
As of June 30, 2024, there were 297.15 shares
of Series K preferred stock issued and outstanding, which the Company was required to, and failed to redeem by April 24, 2022, and was
and remains in default for an aggregate redemption price (equal to the stated value) of $297,150.
Series L
On June 3, 2019, the Company designated 100,000 shares
of preferred stock as Series L, with a stated value of $1,000 per share. Holders of Series L preferred stock are entitled to receive
dividends on an as-converted basis with the Company’s common stock. The Series L preferred stock is convertible into shares of
the Company’s common stock pursuant to the Series L COD, which includes certain make-good shares for certain prior investors. As
of June 30, 2024, there were 320.5 shares of Series L preferred stock issued and outstanding.
Series M
Pursuant to the Amended and Restated
Certificate of Designation of Series M Preferred Stock filed with the Secretary of State of Nevada on July 1, 2020, the Company designated
800,000 shares of its preferred stock as Series M preferred stock, with a stated valued of $25per share. The Series M preferred stock
is not convertible into common stock. Holders of outstanding shares of Series M preferred stock are entitled to receive dividends at the
annual rate of 10%, payable monthly, payable in preference and priority to any payment of dividends on common stock. The Series M preferred
stock is entitled to a liquidation preference equal to $25 per share plus any declared but unpaid dividends before any payments to holders
of common stock.
The Series M preferred stock does
not have pre-emptive or subscription rights, and there are no sinking fund provisions applicable to it. The Series M preferred stock
does not have voting rights, except as required by law and with respect to certain protective provisions set forth in the COD (see ITEM
15. Exhibit 3.29). The Company may, at its sole discretion, redeem any or all of the outstanding shares of Series M Preferred Stock at
a redemption price of $37.50 per share (150% of the stated value) plus any accrued but unpaid dividends. As of June 30, 2024, there were 40,300 shares
of Series M preferred stock issued and outstanding.
Series O
On April 27, 2020, the Company designated 2,000 shares
of preferred stock as Series O preferred stock, with a stated value of $1,000 per share. Holders of Series O preferred stock are
entitled to receive cumulative dividends (i) in cash at an annual rate of 8% of the stated value, and (ii) in shares of common stock
of the Company (valued based on the conversion price as in effect on the last trading day of the applicable fiscal quarter) at an annual
rate of 4% of the stated value, payable quarterly within 60 days from the end of such fiscal quarter. The Series O preferred stock
has a liquidation preference equal to the stated value plus any accrued but unpaid dividends, in preference to the common stock.
The Series O preferred stock has no
preemptive or subscription rights, and there is no sinking fund provision applicable to it. The Series O preferred stock does not have
voting rights except as required by law. The Series O preferred stock is convertible into common stock of the Company in an amount determined
by dividing 200% of the stated value by the conversion price, provided that conversion does not result in the holder beneficially
owning more than 4.99% of the outstanding common stock (which may be increased up to 9.99% upon 61 days’ written notice).
The conversion price is equal to the average closing sale price of the common stock for the five trading days prior to the conversion
date. The Company has the right to redeem the Series O preferred stock at any time at a redemption price equal to the stated value plus
any accrued but unpaid dividends. The cumulative dividends are recorded as interest expense.
During the six months ended June 30,
2024, the Company issued an aggregate of 436,819 shares of common stock in prorated 4% annualized dividends, recorded as interest
expense. The shares were issued within the terms of the agreement and no gain or loss was recognized. During the six months ended June
30, 2024, the Company issued an aggregate of 965,252 shares of common stock upon conversion of 5 shares of Series O preferred
stock. There was no gain or or loss recognized. As of June 30, 2024, there were 185 shares of Series O preferred stock issued
and outstanding.
Series P
On April 27, 2020, the Company designated 500 shares
of preferred stock as Series P preferred stock with a stated value of $1,000 per share. Holders of Series P preferred shares are
entitled to receive dividends on an as-converted basis with the Company’s common stock. The Series P preferred stock is convertible
into stock of the Company pursuant to the Series P COD, which includes certain make-good shares for certain prior investors, provided
that conversion does not result in the holder beneficially owning more than 4.99% of the outstanding common stock (which may be
increased up to 9.99% upon 61 days’ written notice).
The Series P preferred stock entitles
the holders to a payment on an as-converted and pari-passu basis with the common stock upon any liquidation. The Series P preferred stock
has no preemptive or subscription rights, and there is no sinking fund or redemption provisions applicable. The Series P preferred stock
votes on an as-converted basis with the common stock, subject to the beneficial ownership limitation. As of June 30, 2024, there were 30 shares
of Series P preferred stock issued and outstanding.
Series Q
On August 21, 2020, the Company designated
2,000 shares of preferred stock as Series Q Preferred Stock. The Series Q Preferred Stock has a stated value of $1,000 per share and
entitles holders to receive cumulative dividends in cash at an annual rate of 12% of the stated value, payable quarterly within 60 days
from the end of such fiscal quarter. The Series Q Preferred Stock has a liquidation preference equal to the stated value plus any accrued
but unpaid dividends, in preference to the common stock. The Series Q Preferred Stock has no preemptive or subscription rights, and there
is no sinking fund provision applicable. The Series Q Preferred Stock does not have voting rights except as required by law. The Series
Q Preferred Stock is convertible into common stock in an amount determined by dividing 200% of the stated value by the conversion price,
provided that conversion does not result in the holder beneficially owning more than 4.99% of the outstanding common stock (which may
be increased up to 9.99% upon 61 days’ written notice). The conversion price is equal to the average closing sale price of the
common stock for the five trading days prior to the conversion date. The Company has the right to redeem the Series Q Preferred Stock
at any time at a redemption price equal to the stated value plus any accrued but unpaid dividends. The cumulative dividends are recorded
as interest expense.
During the six months ended June 30,
2024, the Company issued an aggregate of 4,576,458 shares of common stock upon conversion of 20 shares of Series Q preferred
stock. No gain or loss was recognized. As of June 30, 2024, there were 410 shares of Series Q preferred stock issued and outstanding.
Series R
On November 16, 2020, the Company
designated 5,000 shares of preferred stock as Series R. The Series R has a stated value of $1,000 per share and entitles holders to receive
cumulative dividends in cash at an annual rate of 10% of the stated value, payable quarterly within 60 days from the end of such fiscal
quarter. The Series R holders are not entitled to any voting rights except as may be required by applicable law. The Series R is convertible
into common stock of the Company in an amount determined by dividing 200% of the stated value by the conversion price; certain prior
investors will also be entitled to certain make-good shares; provided that conversion does not result in the holder beneficially owning
more than 4.99% of the outstanding common stock (which may be increased up to 9.99% upon 61 days’ written notice). The conversion
price is equal to the average closing sale price of the common stock for the five trading days prior to the conversion date. The Company
has the right to redeem the Series R at any time at a redemption price equal to, if paid in cash, the stated value plus any accrued but
unpaid cash dividends, or, if paid in shares of common stock, in an amount of shares determined by dividing the stated value being redeemed
by the conversion price.
During the six months ended June 30,
2024, the Company issued an aggregate of 30,496,772 shares of common stock upon conversion of 135 shares of Series
R preferred stock. No gain or loss was recognized. As of June 30, 2024, there were 1,473 shares of Series R preferred stock
issued and outstanding.
Series S
On February 5, 2021, the Company designated
430 shares of preferred stock as Series S. The Series S has a stated value of $1,000 per share and entitles holders to receive cumulative
dividends in cash at an annual rate of 12% of the stated value, payable quarterly within 60 days from the end of such fiscal quarter.
The Series S holders are not entitled to any voting rights except as required by law. The Series S is convertible into common stock of
the Company in an amount determined by dividing 200% of the stated value by the conversion price, provided that conversion does not result
in the holder beneficially owning more than 4.99% of the outstanding common stock (which may be increased up to 9.99% upon 61 days’
written notice). The conversion price is equal to the average closing sale price of the common stock for the five trading days prior
to the conversion date. The Company has the right to redeem the Series S at a redemption price equal to the stated value plus any accrued
but unpaid dividends.
During the six months ended June 30,
2024, the Company issued an aggregate of 2,272,728 shares of common stock upon conversion of 10 shares of Series S preferred
stock. No gain or loss was recognized. As of June 30, 2024, there were 110 shares of Series S preferred stock issued and outstanding.
Series U
On May 26, 2021, the Company designated
5,000 shares of preferred stock as Series U, with a stated value of $1,000 per share. The Series U holders are not entitled to any dividends
and do not have any voting rights except as required by applicable law. The Series U is convertible into common stock of the Company
in an amount determined by dividing 150% of the stated value of by the conversion price; certain prior investors will also be entitled
to certain make-good shares; provided that conversion does not result in the holder beneficially owning more than 4.99% of the Company’s
outstanding common stock (which may be increased up to 9.99% upon 61 days’ written notice). The conversion price is equal to the
lesser of $0.20 or the average closing sale price of the common stock for the five trading days prior to the conversion date.
The Company has the right to redeem
the Series U at any time at a redemption price equal to, if paid in cash, the stated value, or, if paid in shares of common stock, in
an amount of shares determined by dividing 200% of the stated value being redeemed by the conversion price then in effect, and adding
any applicable make-good shares.
As of June 30, 2024, there were 270 shares of Series U preferred stock along with 1,511,500 warrants with a fair value of $0 (with exercise
price of $1) issued and outstanding. These warrants associated with Series U were valued using the Black Scholes model (See Note 5).
Series W
On April 28, 2021, the Company designated
3,390 shares of preferred stock as Series W, with a stated value of $1,000 per share. Series W holders are entitled to cumulative dividends
in cash at an annual rate of 12%, payable quarterly. The Series W holders are not entitled to any voting rights except as required by
law. The Series W is convertible into common stock of the Company in an amount determined by dividing 200% of the stated value by the
conversion price; provided that conversion does not result in the holder beneficially owning more than 4.99% of the outstanding common
stock. The conversion price is equal to the average closing sale price of the common stock for the five trading days prior to the conversion
date.
The Company has the right to redeem
the Series W at any time at a redemption price equal to the stated value plus any accrued but unpaid dividends. During the six months
ended June 30, 2024, the Company issued an aggregate of 41,715,134 shares of common stock upon conversion of 200 shares
of Series W preferred stock. No gain or loss was recognized. As of June 30, 2024, there were 696.5 shares of Series W preferred
stock issued and outstanding.
Series Y
On December 6, 2021, the Company
designated 3,000 shares of preferred stock as Series Y, with an original issue price of $100,000 per share. Holders are
entitled to receive, on a pro rata and pari passu basis, annual distribution of up to 25% of the annual net profits of newly established,
wholly-owned, WOD subsidiaries, designated by each holder, paid within 3 months of subsidiary’s accounting year-end. The Series
Y holders are not entitled to any voting rights except as required by law. The Series Y is convertible into common stock of the Company
pursuant to the Series Y COD, provided that, the Series Y may not be converted into common stock to the extent such conversion would
result in the holder beneficially owning more than 4.99% of the Company’s outstanding common stock (which may be increased
up to 9.99% upon 61 days’ written notice).
The Company has the right to redeem
the Series Y at any time at a redemption price equal to, if paid in cash, the original issue price plus any accrued but unpaid distributions
of 25% of the subsidiary’s annual net profits. Additionally, the Series Y holders received shares of Series A preferred stock
in the Company’s subsidiary Water On Demand, Inc or warrants to purchase common shares in WODI. During the six months ended June
30, 2024, the Company received aggregate funding in the amount of $575,100 through the sale of Series Y preferred stock and issued an
aggregate of 83,840,346 shares of common stock upon conversion of 4.4 shares of Series Y preferred stock. The shares were issued within
the terms of the agreement and no gain or loss was recognized.
As of June 30, 2024, there were 25.95
shares of Series Y preferred stock along with 55,614,616 warrants with a fair value of $199,084 (with exercise prices between $0.13 and
$0.25) issued and outstanding. The warrants were valued using the Black Scholes model (See Note 5).
Series Z
On February 11, 2022, the Company
designated 25 shares of preferred stock as Series Z, with an original issue price of $10,000 per share. The Series Z holders
were not entitled to dividends or any voting rights. The Series Z was convertible into common stock of the Company pursuant to the Series
Z COD, provided that conversion does not result in the holder beneficially owning more than 4.99% of the Company’s outstanding
common stock (which amount may be increased up to 9.99% upon 61 days’ written notice).
On
February 18, 2022, the Company issued and sold to the Purchaser an aggregate of 25 shares of Series Z preferred stock and
issued an aggregate of 2,500,000 warrants. 25 shares of Series Z were converted
to common stock during the year ended December 31, 2023. As of June 30, 2024,
there were 2,500,000 warrants with a fair value of $7,730 (with an exercise price of $0.10) and no shares of Series Z preferred
stock issued and outstanding. The warrants were valued using the Black Scholes model (See Note 5).
As of June 30, 2024, the Company accrued
aggregate dividends in the amount of $613,215 for all series of preferred stock.
During the six months ended June 30,
2024, the Company redeemed an aggregate of 139,560,037 shares of common stock at a price of $0.01 per share and recognized a gain of $1,255,178
in the condensed consolidated statements of operations relating to settlement and conversion agreements with certain WODI convertible
secured promissory note holders.
The Series J, Series L, Series M,
Series O, Series P, Series Q, Series R, Series S, Series U, Series W, Series Y, and Series Z preferred stock are accounted for outside
of permanent equity due to the terms of conversion at a market component or stated value of the preferred stock.
WODI Preferred Stock
On April 22, 2022, WODI authorized
50,000,000 shares of preferred stock with a par value of $0.0001per share. Due to WODI’s merger with PWT on September 21, 2023
(See Note 10), all series of WODI preferred shares that were previously issued were fully converted to common stock in WODI. As
of December 31, 2023, and June 30, 2024, there were no shares of WODI preferred stock issued and outstanding.
OriginClear, Inc. Common Stock
Six Months Ended June 30, 2024
The Company issued 45,411,996 shares
of common stock for services at a fair value of $412,154, at share prices ranging from $0.0065 - $0.012.
The Company issued 436,819 shares
of common stock for Series O preferred stock dividends payable.
The Company issued 122,213,744 shares
of common stock for settlement of conversion agreements at a fair value of $12,221.
The Company issued 20,937,829
shares of common stock for alternate vesting at a fair value of $169,596.
The Company issued 163,866,690 shares
of common stock upon conversion of $810,000 of preferred stock.
The Company redeemed 139,560,037 shares
of common stock at a market price of $0.01 per share with a gain in the amount of $1,255,178.
Six Months Ended June 30, 2023
The Company
issued 18,645,028 shares of common stock for cash, through an equity financing agreement for a total aggregate of $130,584 based
upon conversion prices ranging from $0.0064 to $0.00816.
The Company
issued 55,788,402 shares of common stock upon conversion of convertible promissory note in the amount of principal of $91,000,
plus accrued interest of $76,365, for a total aggregate of $167,365 based upon a conversion price of $0.0085. The shares were
issued within the terms of the agreements and no gain or loss was recognized.
The Company
issued 45,217,435 shares of common stock for services at fair value of $424,926, at share prices ranging from $0.0051 to
$0.0135.
The Company
issued 498,280 shares of common stock for Series O preferred stock dividends payable.
The Company
issued 11,584,932 shares of common stock for alternate vesting at a fair value of $1,158.
The Company
issued 265,181,982 shares of common stock for settlement of conversion agreements at a fair value of $26,518.
The Company
issued 478,402,031 shares of common stock upon conversion of $2,510,000 of preferred stock. The shares were issued
within the terms of the agreements and no gain or loss was recognized.
The Company
redeemed 589,253,845 shares of common stock at a market price of $0.01 per share in the amount of $5,403,828.
WODI Common Stock
Non-controlling Interest
As of June 30, 2024, WODI had issued
and outstanding shares, of which, the Company owns 90.83%, with a minority, non-controlling interest of 9.17%. The following table shows
WODI ownership percentage as of June 30, 2024:
WODI common stock holders | |
Ownership
% | |
OriginClear, Inc. | |
| 90.83 | % |
Prior Reg A Holders | |
| 0.19 | % |
Prior Series A Holders | |
| 3.87 | % |
Prior Series B Holders | |
| 5.11 | % |
Total | |
| 100 | % |
5. |
Restricted Stock Grants
and Warrants |
Restricted Stock Grants to CEO,
the Board, Employees and Consultants
Between May 12, 2016, and August 4,
2022, the Company entered into Restricted Stock Grant Agreements (“ RSGAs”) with its Chief Executive Officer, the Board,
employees, and consultants to create management incentives aimed at improving the Company’s economic performance and increasing
its value and stock price. All shares issuable under the RSGAs are performance-based shares. The RSGAs provide for the issuance of shares
of the Company’s common stock provided certain milestones are met. These milestones are (a) if the Company’s consolidated
gross revenue, calculated in accordance with generally accepted accounting principles, consistently applied, equals or exceeds $15,000,000 for
the trailing twelve month period as reported in the Company’s quarterly or annual financial statements, and b) If the Company’s
consolidated operating profit (Operating Profit = Operating Revenue - Cost of Goods Sold - Operating Expenses - Depreciation &
Amortization), calculated in accordance with generally accepted accounting principles, equals or exceeds $1,500,000 for the
trailing twelve month period as reported in the Company’s SEC Reports.
The Company has not recognized any
costs associated with these milestones because achievement is not probable.
On August 14, 2019, the Board of Directors
approved an amendment to the RSGAs to include an alternative vesting schedule for the grantees, and on January 26, 2022, the Company
amended the procedures for processing the RSGAs. If the fair market value of the Company’s common stock on the date the shares
vest is less than the fair market value of the Company’s common stock on the effective date of the RSGAs, the number of vested
shares issuable (assuming all conditions are satisfied per terms of the alternative vesting schedule) shall be increased so that the
aggregate fair market value of vested shares on the vesting date equals the aggregate fair market value that such number of shares would
have had on the effective date. Upon the occurrence of a Company performance goal, the right to participate in the alternate vesting
schedule will terminate, and the vesting of the remaining unvested shares will follow the original RSGAs terms. Shares are issued under
the alternate vesting schedule per terms of the agreements after electing and qualifying requirements are met.
During the six months ended June 30,
2024, upon qualifying under the alternative vesting schedule, the Company issued an aggregate of 20,937,829 shares relating to the RSGAs
and recognized an aggregate expense of $169,599 which is reflected on the financial statements as stock-based compensation.
Warrants
During the six months ended June 30, 2024, the Company issued
1,427,049 warrants for proceeds in the amount of $426,230 and issued 2,020,000 purchase warrants associated with the preferred stocks,
with an exercise price of $1.00 and a term of three years. A summary of the Company’s warrant activity and related information for
the six months ended June 30, 2024, is as follows:
| |
| | |
Weighted | |
| |
| | |
average | |
| |
Number of | | |
exercise | |
| |
Warrants | | |
price | |
Outstanding - beginning of period | |
| 64,401,089 | | |
$ | 0.1383 | |
Granted | |
| 4,600,800 | | |
$ | 0.1250 | |
Exercised | |
| - | | |
$ | - | |
Expired | |
| (48,500 | ) | |
$ | 1.0000 | |
Outstanding - end of period | |
| 68,953,389 | | |
$ | 0.1368 | |
At June 30, 2024, the weighted average
remaining contractual life of warrants outstanding:
| | | | | | | | | Weighted | |
| | | | | | | | | Average | |
| | | | | | | | | Remaining | |
Exercisable | | | Warrants | | | Warrants | | | Contractual | |
Prices | | | Outstanding | | | Exercisable | | | Life (years) | |
$ | 0.0200 | | | | 600,000 | | | | 600,000 | | | | 2.17 | |
$ | 0.1000 | | | | 2,500,000 | | | | 2,500,000 | | | | 6.91 | |
$ | 0.2500 | | | | 3,760,000 | | | | 3,760,000 | | | | 2.64 | |
$ | 0.0275 | | | | 8,727,273 | | | | 8,727,273 | | | | 3.20 | |
$ | 0.1250 | | | | 51,854,616 | | | | 51,854,616 | | | | 2.47 | |
$ | 1.0000 | | | | 1,511,500 | | | | 1,511,500 | | | | 0.23 | |
| | | | | 68,953,389 | | | | 68,953,389 | | | | | |
The derivative liability recognized
in the financial statements for the warrants as of June 30, 2024 was $234,791.
At June 30, 2024, the aggregate intrinsic
value of the warrants outstanding was $0.
6. |
Convertible Promissory
Notes |
OriginClear, Inc.
As of June 30, 2024, the outstanding
convertible promissory notes are summarized as follows:
Convertible promissory notes | |
$ | 2,617,691 | |
Less current portion | |
| 597,944 | |
Total long-term liabilities | |
$ | 2,019,747 | |
Maturities of long-term debt for the
next three years are as follows:
Period ending June 30, | |
Amount | |
2024 (remaining 6 months) | |
| - | |
2025 | |
| 82,472 | |
2026 | |
| 1,875,000 | |
2027 | |
| - | |
2028 | |
| 62,275 | |
| |
$ | 2,019,747 | |
2014-2015 Notes
On various dates from November 2014
through April 2015, the Company issued unsecured convertible promissory notes (the “2014-2015 Notes”), which matured on various
dates and were extended for an additional sixty months from the effective date of each note. The 2014-2015 Notes bear interest at 10%
per year, with maturity dates extended to November 2023 through April 2026. These notes may be converted into shares of the Company’s
common stock at conversion prices ranging from the lesser of $4,200 to $9,800 (subject to adjustment for stock splits, dividends,
combinations and other similar transactions) or 50% of the lowest trade price on any trade day following issuance of the 2014-2015
Notes. In addition, for as long as the 2014-2015 Notes or other convertible notes between the purchaser and the Company are outstanding,
if the Company issues any security with terms more favorable than the terms of the 2014-2015 Notes or such other convertible notes or
a term was not similarly provided to the purchaser of the 2014-2015 Notes or such other convertible notes, then such more favorable or
additional term shall, at the purchaser’s option, become part of the 2014-2015 Notes and such other convertible notes. The conversion
feature of the 2014-2015 Notes was considered a derivative in accordance with current accounting guidelines due to the reset conversion
features. As of June 30, 2024, the 2014-2015 Notes had an aggregate remaining balance of $683,700, classified as long term.
OID Notes
The unsecured original issue discount
(OID) convertible promissory notes had an aggregate remaining balance of $184,124, plus accrued interest of $13,334. The OID Notes included
an original issue discount and one-time interest, which has been fully amortized. The OID Notes matured on June 30, 2023, and were extended
to June 30, 2028. These notes were convertible into shares of the Company’s common stock at a conversion price initially of
$30,620 amended to the lesser of $5,600 per share, fifty percent (50%) of the lowest trade price of common stock recorded since
the original effective date of this note, or the lowest effective price per share granted to any person or entity after the effective
date. The conversion feature of the OID Notes was considered a derivative in accordance with current accounting guidelines, because of
the reset conversion features of the OID Notes. During the year ended December 31, 2023, an addendum to the OID Notes was effectuated
to accrue interest on a monthly basis. As of June 30, 2024, the remaining balance on the OID Notes was $62,275, classified as long- term.
2015 Notes
The Company issued various unsecured
convertible promissory notes (the “2015 Notes”) on various dates, with the last issued in August 2015. The 2015 Notes matured
and were extended from the date of each tranche through maturity dates ending in February 2026 through August 2026, bearing interest
at 10% per year. These notes are convertible into shares of the Company’s common stock at conversion prices ranging from the lesser
of $1,400 to $5,600 (subject to adjustment for stock splits, dividends, combinations and other similar transactions) or 50%
of the lowest trade price on any trade day following issuance. The conversion feature of the 2015 Notes was considered a derivative due
to the reset conversion features. As of June 30, 2024, the 2015 Notes had an aggregate remaining balance of $1,200,000, classified as
long-term.
Dec 2015 Note
The Company issued a convertible note
(the “Dec 2015 Note”) in exchange for accounts payable in the amount of $432,048, which could be converted into shares of
the Company’s common stock after December 31, 2015. Initially accounted for under ASC 470 with a beneficial conversion feature,
it was later accounted for under ASC 815, as a derivative due to reset conversion features. The Dec 2015 Note has zero stated
interest rate, with a conversion price equal to 75% of the average three lowest last sale prices traded during the 25 trading days
immediately prior to conversion. As of June 30, 2024, the remaining balance on the Dec 2015 Note was $167,048, classified as short-term.
Sep 2016 Note
The Company issued a convertible note
(the “Sep 2016 Note”) in exchange for accounts payable in the amount of $430,896, which could be converted into shares of
the Company’s common stock after September 15, 2016. Initially accounted for under ASC 470 with a beneficial conversion feature,
it was later accounted for under ASC 815 as a derivative due to reset conversion features. The Sep 2016 Note has zero stated
interest rate, with a conversion price shall be equal to 75% of the average three lowest last sale prices traded during the 25 trading
days immediately prior to conversion. As of June 30, 2024, the remaining balance on the Sep 2016 Note was $430,896, classified as short-term.
Nov 2020 Note
On November 19, 2020, the Company
entered into an unsecured convertible promissory note (the “Nov 2020 Note”) for $50,000. The Nov 2020 Note had an original
maturity date of November 19, 2021 and was extended for an additional sixty months from the maturity date, bearing interest at 10% per
year. The Nov 2020 Note may be converted into shares of the Company’s common stock at a lesser price of $0.05 per share, 50%
of the lowest trade price of common stock recorded on any trade after the effective date, or the lowest effective price per share granted.
If shares are not delivered by the fourth business day (inclusive of the day of conversion), a penalty of $2,000 per day is assessed
for each day after the third business day until delivery. The conversion feature was considered a derivative due to the reset conversion
features. As of June 30, 2024, the remaining balance on the Nov 2020 Note was $13,772, classified as long-term.
Jan 2021 Note
On January 25, 2021, the Company entered
into an unsecured convertible promissory note (the “Jan 2021 Note”) for $60,000. The Jan 2021 Note had an original maturity
date of January 25, 2022, and was extended for an additional sixty months from the maturity date, bearing interest at 10%
per year. The Jan 2021 Note may be converted into shares of the Company’s common stock at a conversion price equal to the lower
of $0.05 per share, 50% of the lowest trade price of common stock recorded on any trade after the effective date, or the lowest
effective price per share granted. If shares are not delivered by the fourth business day (inclusive of the day of conversion), a penalty
of $2,000 per day shall be assessed for each day after the third business day until delivery. The conversion feature of the Jan
25 Note was considered a derivative due to the reset conversion features. As of June 30, 2024, the balance of the Jan 2021 Note was $60,000,
classified as long-term.
Evaluation of Convertible Promissory
Notes
The Company evaluated the financing
transactions in accordance with ASC Topic 815, Derivatives and Hedging, and determined that the conversion features of the convertible
promissory notes were not afforded the exemption for conventional convertible instruments due to variable conversion rates. The notes
have no explicit limit on the number of shares issuable, so they did not meet the conditions set forth for equity classification. The
Company elected to recognize the note under paragraph 815-15-25-4, whereby, there would be a separation into a host contract and derivative
instrument. The Company elected to initially and subsequently measure the note in its entirety at fair value, with changes in fair value
recognized in earnings. The Company recorded a derivative liability representing the imputed interest associated with the embedded derivatives.
The derivative liability is adjusted periodically according to the stock price fluctuations.
Derivative Liability
The derivative liability recognized
in the financial statements for the convertible promissory notes as of June 30 31, 2024 was $14,101,479.
WODI
During the six months ended June 30,
2024, WODI raised capital in the amount of $2,042,500 by issuing convertible secured promissory notes to investors, bearing interest at
a rate of 10% interest per annum. Additionally, during the period ended June 30, 2024, as part of settlement, conversion and redemption
agreements with WODI shareholders, an aggregate of 139,560,037 shares of the Parent Company’s common stock were redeemed at the
closing share prices on the dates of the convertible secured promissory note agreements. This fair value of redeemed common stock was
added to the cash value of the shareholders’ investments to purchase WODI convertible secured promissory notes. The
loss relating to these settlement and conversion agreements, amounting to $1,297,000 was accounted for in the condensed consolidated
statements of operations. As of June 30, 2024, WODI had outstanding convertible secured promissory notes in the aggregate amount of $20,068,589.
7. |
Revenue from Contracts
with Customers |
Equipment Contracts
Revenues and related costs on equipment
contracts are recognized as the performance obligations are satisfied over time in accordance with ASC 606, Revenue from Contracts with
Customers. Under ASC 606, revenue and associated profit will be recognized as the customer obtains control of the goods and services promised
in the contract (i.e., performance obligations). All un-allocable indirect costs and corporate general and administrative costs are charged
to the periods as incurred. However, if a loss on a contract is foreseen, the Company will recognize the loss as it is determined.
The following table present the Company’s
revenues disaggregated by revenue sources:.
| |
Six Months Ended | |
| |
June 30, | |
| |
2024 | | |
2023 | |
Equipment Contracts | |
$ | 1,167,482 | | |
$ | 1,980,345 | |
Component Sales | |
| 715,977 | | |
| 378,872 | |
Pump Stations | |
| 487,791 | | |
| 305,712 | |
Waste Water Treatment Systems | |
| 134,262 | | |
| 1,124,075 | |
Services Sales | |
| 72,184 | | |
| 33,015 | |
Commission & Training | |
| 26,500 | | |
| 1,913 | |
Rental Income | |
| 6,573 | | |
| 13,146 | |
| |
$ | 2,610,769 | | |
$ | 3,837,078 | |
Aggregate revenue of $6,573 and $13,146
from continued operations for the six months ended June 30, 2024 and 2023, respectively, and aggregate revenue from discontinued operations
was $2,604,196 and $3,823,932 for the six months ended June 30, 2024 and 2023, respectively.
Revenue recognition for other sales
arrangements, such as sales for components, and service sales will remain materially consistent.
Contract assets represent revenues
recognized in excess of amounts billed on contracts in progress. Contract liabilities represent billings in excess of revenues recognized
on contracts in progress. Assets and liabilities related to long-term contracts are included in current assets and current liabilities
in the accompanying condensed consolidated balance sheets, as they will be liquidated in the normal course of the contract completion.
The contract asset for the six months
ended June 30, 2024 and the year ended December 31, 2023, was $476,906 and $445,102, respectively. The contract liability for the six
months ended June 30, 2024, and the year ended December 31, 2023, was $1,619,759 and $1,346,366, respectively.
Fair value investment in Securities
On May 15, 2018, the Company received 4,000 shares
of WTII Series C convertible preferred stock for the use of OriginClear, Inc.’s technology associated with their proprietary electro
water separation system. Each share of Series C convertible preferred stock is convertible into 1,000 shares of WTII common stock. The
stock was valued at fair market value of $0.0075 per share, totaling $30,000 on the date of issuance. The Company analyzed
the licensing agreement using ASU 606 to determine the timing of revenue recognition. The licensing of intellectual property (IP) is
distinct from the non-license goods or services and has significant standalone functionality that provides a benefit or value. This functionality
does not change during the license period due to the licensor’s activities. Because the significant standalone functionality was
delivered immediately, the revenue was recognized in the condensed consolidated financial statements as of June 30, 2018. As of June
30, 2024, the fair value of the preferred shares was $3,200, with no loss in fair value.
On
November 12, 2021, the Company served a conversion notice to WTII and was issued an aggregate of 45,208,649 shares of WTII common
stock. As of June 30, 2024, the investment in securities was recorded at fair value in the amount of $36,167.
Secured Loans Payable
In 2018, the Company entered into
short-term loans with various lenders for capital expansion, secured by the Company’s assets, in the amount of $1,749,970, which
included finance cost of $624,810. The finance costs were amortized over the terms of the loans, which had various maturity dates ranging
from October 2018 through February 2019. As of December 31, 2020, the finance cost was fully amortized. The term of the loans ranged
from two months to six months. The net balance as of June 30, 2024 was $0.
On December 6, 2023, the Company entered
into short-term loan arrangement with a lender, secured by the Company’s assets, in the amount of $149,900, which included finance
cost of $59,900. These finance costs were expensed upon initiation of the loan, resulting in a net amount of $90,000 received by the
Company. The loan was fully paid off during the six months ended June 30, 2024 and as of June 30, 2024, the balance outstanding is $0.
Settlement of Liability with C6
Capital LLC
On March 12, 2021, the Company, through
it’s subsidiary PWT entered into a settlement agreement with C6 Capital LLC to resolve a dispute regarding merchant cash agreement.
As part of the settlement, C6 Capital vacated the judgment against the company, released all encumbrances, and the Company was released
from any further amounts owed to C6 Capital.
As a result, the Company recognized
a gain of $30,646 during the six months ended June 30,2024, related to the write-off of the remaining liability attributed to C6 Capital.
This gain is reflected in the consolidated statement of cash flows, Gain on the extinguishment of debt.
Small Business Administration Loan
On June 12, 2020, the Company received
an Economic Injury Disaster Loan (the “EIDL”) in the amount of $150,000. Following the deferral period for the EIDL, the
Company started to repay the principal amount, with interest, on a monthly basis. As of June 30, 2024, the remaining balance on the EIDL
was $145,890.
Receivables Financing Agreement
On May 13, 2024, the Company entered
into a Future Receivables Agreement with Lee Advance LLC. Under this agreement, the Company received $150,000 in exchange for selling
11% of its future receivables until a total of $225,000 is repaid. The agreement grants Lee Advance LLC a security interest in all of
the Company’s assets, including accounts, equipment and inventory. The origination fee for this agreement was $15,000 and the payments
are made weekly, based on a specified percentage of daily receipts. As of June 30, 2024, the balance outstanding under this arrangement
is $145,250.
In addition to the origination fee, the financing arrangement
includes an additional $75,000 recognized as debt discount. This $90,000 is recognized as an interest expense and amortized over the term
of the agreement. This amortization is reflected in the consolidated statement of cash flows under Debt discount recognized as interest
expense.
WODI was incorporated in the state
of Nevada on April 22, 2022. WODI, with the support of its parent, the Company, is developing a new outsourced water treatment business
called WOD. The WOD model intends to offer private businesses the ability to pay for water treatment and purification services on a per-gallon
basis, commonly known as DBOO. WODI intends to work with regional water service companies to build and operate the water treatment systems
it finances.
On November 16, 2022, WODI filed a
Form 1-A Offering Circular for an offering under Regulation A (the “WODI Reg A Offering”) of the Securities Act of 1933 with
the U.S. Securities and Exchange Commission. The purpose of the WODI Reg A Offering is to allow potential investors the opportunity to
invest directly in WODI. The Offering had a minimum investment of $1,000 per investor and was conducted on a best-efforts basis.
An aggregate of 12,000 shares were sold for total proceeds of $60,000 under the WODI Reg A Offering. The WODI Reg A Offering was suspended
in June 2023.
On December 22, 2022, WODI entered
into a Membership Interest Purchase and Transfer Agreement (the “Purchase Agreement”) with Ka Wai Cheung, Koon Lin Chan,
and Koon Keung Chan (each a “Seller”, and collectively, the “Sellers”) and Fortune Rise Sponsor LLC, a Delaware
limited liability company (the “Sponsor”), pursuant to which WODI purchased 100 membership interests in the Sponsor (“Purchased
Interests”) from the Sellers, which constitutes 100% of the membership interests in the Sponsor. The Sponsor owns 2,343,750 shares
out of 2,443,750 shares of the issued and outstanding shares of Class B common stock (the “Class B Common Stock”)
of FRLA. On December 29, 2022, the Company announced that its subsidiary, WODI had closed its acquisition of Fortune Rise Sponsor, LLC,
which is the sponsor of FRLA.
On December 22, 2022, WODI paid a
total of $1,137,267 to the Sellers of Fortune Rise Sponsor, LLC which included a total of $400,000 to purchase the membership
interest in Class B Common Stock of FRLA and $737,267 for compensating the payment made by the Sellers on November 4, 2022, towards
the first extension of the SPAC through February 5, 2023. In connection with the Extension Payment, FRLA issued unsecured promissory
notes to the Sellers. As of December 31, 2022, the $737,267 amount was reflected as Notes Payable to related party on the consolidated
balance sheet of the SPAC. To acquire the equity interests in FRLA for the purchase price of $400,000, WODI issued convertible secured
promissory notes to investors at 10% interest per annum. Per the terms and conditions of the convertible promissory note, all unpaid
principal, together with any unpaid and accrued interest shall be due and payable on the earlier of the twelve (12) month of the date
of the Note (the “Maturity Date”) (provided, WODI shall have the option to extend the Maturity Date for up to two (2) six-month
extensions), or (ii) when, upon the occurrence and during the continuance of an Event of Default.
FRLA is a blank check company incorporated
in February 2021 as a Delaware corporation formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock
purchase, reorganization or similar business combination with one or more businesses. FRLA is a “shell company” as defined
under the Exchange Act of 1934, as amended, because it has no operations and nominal assets consisting almost entirely of cash. The SPAC
will not generate any operating revenues until after the completion of its initial business combination, at the earliest.
On January
5, 2023, WODI signed a non-binding LOI with FRLA, (“FRLA” collectively with WODI, the “Parties”). The LOI is
not binding on the Parties and is intended solely to guide good-faith negotiations toward a definitive business combination agreement.
The Parties will work together in good faith with their respective advisors to agree on a structure for the business combination that
is most expedient to the consummation of the acquisition, which may result in a new (merged) entity. Pursuant to the LOI, if a business
combination were to be consummated and approved, all of the outstanding equity securities of WODI, including all shares of common stock,
preferred stock, outstanding options and warrants will convert into new equity of the merged entity.
On February 7, 2023, FRLA and OriginClear
Inc. announced that WODI deposited $977,500 (the “Second Extension Payment”) into FRLA’s trust account for its
public shareholders, representing $0.10 per public share, which enables FRLA to extend the period of time it has to consummate its
initial business combination by an additional three months from February 5, 2023 to May 5, 2023 (the “Second Extension”).
WODI assumed the obligation to make
any necessary extension payments in connection with the extension of the period of time in which the SPAC may consummate its initial
business combination as described in the SPAC’s S-1 Registration Statement, including the three-month extension from November 5,
2022 to February 5, 2023, the Second Extension for an additional three months from February 5, 2023 to May 5, 2023 and a final extension
for an additional six months from May 5, 2023 to November 5, 2023.
On April 10, 2023, at the Special
Meeting, a total of 10,514,410 (or 81.61%) of FRLA’s issued and outstanding shares of Class A common stock and Class
B common stock held of record as of March 3, 2023, were present either in person or by proxy, which constituted a quorum. In that FRLA
shareholders agreed to an extension of the period of time it has to consummate its initial business combination by an additional six
months from May 5, 2023 to November 5, 2023. FRLA’s stockholders voted on to approve and adopt the extension amendment which received
sufficient votes (more than 65%) for approval.
On April
14, 2023, WODI entered into an Asset Purchase Agreement with the Company, whereby it agreed to purchase all of the assets related to
the Company’s “Modular Water Service” business, including licenses, technology, intellectual property, contracts, business
models, patents and other assets in exchange for 6,000,000 shares of WODI common stock. The assets included MWS accounts receivables
and accounts payables as of April 14, 2023 and an assignment of the Company’s existing global master license to the patents of
inventor Daniel M. Early, P.E., who heads MWS, and the right to file patents for all additional inventions since 2018, when OriginClear
created the MWS unit. Beginning on the Effective Date, all MWS transactions including revenue, accounts payable and accounts receivable
were transferred from the Company’s PWT subsidiary over to the Company’s WODI subsidiary.
On September 21, 2023, WODI entered
into a merger agreement with PWT to create better enterprise value for a potential merger opportunity with FRLA and a plan of merger
agreement (the “PWT-WODI merger agreement”) was entered into between WODI and PWT. Per the PWT-WODI merger agreement, all
shares of WODI common and preferred stock were exchanged for shares of PWT common stock as merger consideration. WODI convertible
notes and WODI Restricted Stock Grants were assumed by PWT and remain outstanding. WODI Series A and Series B were converted to WODI
common stock prior to the merger.
In connection with the merger with
WODI, PWT changed its name to Water on Demand, Inc.
Before issuing common stock to WODI
stockholders in the PWT Merger, PWT had 10,000,000 common shares issued and outstanding, which were fully owned by OCLN. Post PWT-WODI
merger, OCLN received an aggregate of 2,171,068 shares of WODI.
On September
28, 2023, the LOI executed on January 5, 2023 with WODI was amended to designate PWT as the new target of the acquisition. Under
the amended LOI, FRLA proposed to acquire all the outstanding securities of the new combined WODI/PWT entity, based on certain material
financial and business terms and conditions being met. The LOI is not binding on the parties and is intended solely to guide good-faith
negotiations toward definitive agreements.
On October
24, 2023 FRLA and WODI entered into a definitive business combination agreement (the “BCA”).
On October 25, 2023, at the Special
Meeting, a total of 5,687,847 (or 84.59%) of FRLA’s issued and outstanding shares of Class A common stock and Class
B common stock held of record, were present either in person or by proxy, which constituted a quorum. FRLA shareholders approved a proposal
to extend the period of time FRLA has to consummate its initial business combination by an additional one year from November
5, 2023 to November 5, 2024, by up to twelve one-month extensions, subject to certain conditions.
Promissory Notes
Since
acquiring the sponsorship interest in the SPAC on December 22, 2022, through June 30, 2024, WODI and the Company made payments on behalf
of the SPAC in the aggregate amount of $5,051,985. As of June 30, 2024, WODI and the Company received an aggregate of $5,051,985 in
unsecured promissory notes (the “SPAC Notes”) from the SPAC in exchange for the payments
made on behalf of the SPAC to meet its operating expenses and the extension payments. The SPAC Notes are non-interest bearing and
payable (subject to the waiver against SPAC trust provisions) on the earlier of (i) consummation of the SPAC initial business combination;
or (ii) the date of the liquidation of the SPAC. The principal balance of each SPAC Note may be prepaid at any time, at the election
of the SPAC.
As of the date of this filing, the
SPAC has been extended through November 5, 2024, to give the Company adequate time to complete all the necessary administrative and regulatory
steps, including filing of the registration statement and timely respond to satisfy potential comments, from regulatory bodies to consummate
the business combination. Management estimates the likelihood of completing the business combination at 75%.
Impairment of receivable
Although the payments made on behalf
of the SPAC are amounts receivable to WODI, for the period ended June 30, 2024, WODI considered the aggregate amount of $1,128,000 for
the SPAC Notes to be impaired and recorded it as an expense on the consolidated income statements, as it is deemed probable that the
SPAC may not have funds to pay back with interest all of the Class A shareholders and WODI for the amounts advanced to the SPAC. In the
event of WODI successfully merging with the SPAC, all amounts paid by WODI on behalf of the SPAC, including any future payments made
until such merger is fully consummated will be received back by WODI.
Recording
of membership interest
As of June
30, 2024, WODI recorded the purchase of Class B Founder Shares at lower of cost or market at $400,000 on the condensed consolidated
balance sheet as other asset held-for-sale.
Impairment
analysis for Class B Common Founder Shares as of June 30, 2024
The Company
retained an independent valuation firm for the purpose of conducting a valuation of the fair value of Sponsor Founder Shares (Class B)
of FRLA as of December 31, 2023.
The independent
firm (i) evaluated and analyzed various Sponsor Founder Shares of FRLA; (ii) assessed the terms including various redemption and liquidation
features considering each of the Company’s financial plans and market conditions; and (iii) determined the underlying value to
be assigned to the FRLA Sponsor Founder Shares as of the Date of Valuation and evaluated the FRLA Sponsor Founder Shares for impairment
by performing the following procedures:
|
● |
Analyzed the Company’s
S-4 filing, business combination agreement and other documentation. |
| ● | Developed Monte Carlo Model that values the FRLA Sponsor Founder Shares based on a multipath random event model and future projections of the various potential outcomes. The Monte Carlo Model simulation included 50,000 iterations and simulated the stock price, the timing of the business combination, and the timing of the lapse of the transfer restrictions. |
| | |
| ● | Developed the discounted cash flow from the sale of the securities at the time the restrictions terminated. |
| | |
| ● | Probability weighted the cash flow, discounted for lack of marketability. |
|
● |
Valued the FRLA Sponsor
Founder Shares as of the date of valuation. |
Based on
the procedures performed the independent valuation firm concluded that the value of FRLA Sponsor Founder Shares was not impaired.
Restricted Stock to WODI Board,
Employees and Consultants
Between August 12, 2022, and August
3, 2023, WODI entered into Restricted Stock Grant Agreements (the “WODI RSGAs”) with its members of the Board, employees,
and consultants to create management incentives to improve the economic performance of WODI and to increase its value. WODI RSGAs provide
for the issuance of up to 15,550,000 shares of WODI common stock provided certain milestones and vesting are met in certain
stages. The restricted shares may become fully vested and no longer subject to risk of forfeiture (“Vested Shares”)
if WODI shares are uplisted to a National Exchange, then upon such uplisting, 25% of the restricted shares that shall vest and become
Vested Shares and 6.25% each three-month period thereafter, subject to the following: (i) If WODI shares are traded on a National
Exchange, then the amount of restricted shares which shall become Vested Shares during any three-month period shall not exceed an amount
representing the greater of (a) 1% of the shares of common stock outstanding as shown by the most recent SEC Report published by
WODI and (b) the average weekly reported volume of trading in the common stock on a national securities exchange during the previous
four calendar weeks. (ii) If WODI shares are subsequently delisted and quoted on the over-the-counter market, including the OTCQB, then
the amount of restricted shares which shall become Vested Shares during any three month period shall not exceed an amount representing 1%
of the shares of common stock outstanding as shown by the most recent SEC Report published by WODI, or if WODI shares are traded on a
national securities exchange, the greater of (b)(i) and the average weekly reported volume of trading in the common stock on a national
securities exchange during the previous four calendar weeks. If WODI shares do not achieve listing on a national securities exchange
within three years of the Effective Date, then the restricted shares shall vest and become Vested Shares at a rate equal to 25%
on the three-year anniversary of the Effective Date and 6.25% each three-month period thereafter. WODI has not recognized any costs
associated the WODI RSGAs because milestones and vesting have not been achieved. As the milestones are achieved, the shares shall
become eligible for vesting and issuance. On September 21, 2023, per the Merger Plan Agreement and per the conversion ratio of 0.19737
established in the Merger Plan Agreement, the 15,550,000 total issuable shares under the WODI RSGAs were converted to 3,069,100 total
issuable shares. On October 23, 2023, certain WODI RSGAs were canceled and new WODI RSGAs were issued. As of June 30, 2024, there were
2,581,344 total issuable shares under the WODI RSGAs. As the milestones are achieved, the shares shall become eligible for vesting and
issuance. During the six months ended June 30, 2024, no issuable shares under the WODI RSGAs vested and no costs associated with the
milestones were recognized because achievement is not probable.
During the year ended December 31, 2023,
the Company obtained 12-month credit lines in the aggregate amount of $345,875, with an interest rate of 26.07%. Through June 30,
2024, the Company paid principal in the amount of $292,812, leaving a principal balance of $53,063 as of June 30, 2024.
12. |
Assets Held for Sale
– Continuing Operations |
On March
1, 2021, the Company issued an aggregate of 630 shares of Series T preferred stock to the Purchaser per terms of a SPA. According
to the SPA, the Purchaser agreed to purchase from the Company, 630 shares of the Company’s Series T preferred stock,
along with two-year cashless warrants to acquire 25,200,000 shares of the Company’s common stock, valued at $0.05 per
share. These warrants were exercisable at any time, in whole or in part. In lieu of the purchase price for the Series T preferred stock,
the Purchaser transferred to the Company real property in Buenos Aires, Argentina, with an aggregate value agreed to be $630,000 based
on an appraisal from an international independent company at that time. The real property was recorded at $630,000 upon exchange for
the 630 shares of Series T preferred stock.
Based on
indicators of impairment, during the year ended December 31, 2021, the Company adjusted the original value of the asset held for sale
from $630,000 to $514,000 and recorded an impairment of $116,000 in the consolidated financial statements.
During the
period ended December 31, 2022, after evaluating several offers, the Company considered an offer for $400,000, which was $114,000 below
the previously adjusted value and was indicative of the real estate market conditions in Buenos Aires, Argentina. Based on this indicator
of impairment, the Company further adjusted the value of the assets held for sale from $514,000 to $400,000 on the condensed
balance sheet and recorded an additional impairment of $114,000 in the consolidated financial statements. All Series T preferred
stock was converted, and the warrants associated with the Series T expired during the period ended December 31, 2022.
In January
2023, the Company accepted the offer, and on April 8, 2023, a deed was executed for the sale of the property for $400,000. The agreed
upon payment terms were an initial payment of $235,000, with the remaining $165,000 to be paid over fifteen monthly installments
of $11,000 each. The initial payment was received by SMS , an accounting and consulting firm that was appointed by the Company as
the Power of Attorney for the property. From the proceeds, SMS remitted taxes due on the transaction to the AFIP, which administers taxation
in Argentina. On June 21, 2023, the Company received a payment of $164,935, net of all taxes assessed by AFIP and other closing fees
associated with the sale of the property totaling $65,493 and recorded a receivable of $169,572 for the remaining balance.
As of June 30, 2024, the balance of the receivable was $33,000 which is reflected on the consolidated financial statements.
13. |
Commitments and Contingencies |
Facility Rental – Related
Party
Our Dallas based subsidiary, PWT,
rents an approximately 12,000 square foot facility located at 2535 E. University Drive, McKinney, TX 75069, with a current monthly rent
of $8,500.
Warranty Reserve
Generally, a PWT project is guaranteed
against defects in material and workmanship for one year from the date of completion, while certain areas of construction and materials
may have guarantees extending beyond one year. The Company maintains various insurance policies relating to the guarantee of completed
work, which, in the opinion of management, will adequately cover any potential claims. A warranty reserve has been established based
on management’s assessment and Company history in the amount of $20,000 for six months ended June 30, 2024 and the year ending
December 31, 2023.
Litigation
There are
no material updates to the litigation matters with Process Solutions, Inc. as previously disclosed in the Form 10-K filed on April 18,
2024.
Management
has evaluated subsequent events in accordance with ASC Topic 855 and has identified
the following subsequent events:
OCLN
Preferred Stock Conversions
| ● | On July 12, 2024, July 24, 2024, and August 1, 2024, holders converted a total of 0.82 Series Y shares into 18,927,182 common shares at conversion prices ranging from $0.0068 to $0.0071 per share. |
OCLN
Stock Cancellations by WODI Notes:
| ● | On July 3, 2024, July 12, 2024, July 24, 2024, August 1, 2024, and August 7, 2024, a total of 52,271,686 common shares of OCLN stock were redeemed and canceled per WODI Notes, which the value applied as credits to the respective notes. |
Shares
issued for services:
| ● | On
July 1, 2024, July 15, 2024, and July 31, 2024, a total of 5,788,449 common shares of OCLN stock were issued for consulting and advisory
services in connection with various agreements. |
Series Y Shares
| ● | Between July 1, 2024 and August 12, 2024, the company entered
into subscription agreements with certain accredited investors pursuant to which the Company sold an aggregate of 3.25 shares of the
Company’s series Y preferred stock for an aggregate purchase price of $325,000. The Company also issued an aggregate of 2,600,000
warrants to purchase common shares to its investors. |
ITEM 2. MANAGEMENT’S
DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS
This Quarterly Report
on Form 10-Q contains forward-looking statements that are subject to a number of risks and uncertainties, many of which are beyond our
control, which may include statements about our:
|
● |
future operating results;
and |
|
● |
plans, objectives, expectations,
and intentions contained in this report that are not historical. |
All statements, other
than statements of historical fact included in this report, regarding our strategy, intellectual property, future operations, financial
position, estimated revenues and losses, projected costs, prospects, plans and objectives of management are forward-looking statements.
When used in this report, the words “could,” “believe,” “anticipate,” “intend,” “estimate,”
“expect,” “project” and similar expressions are intended to identify forward-looking statements, although not
all forward-looking statements contain such identifying words. All forward-looking statements speak only as of the date of this report.
You should not place undue reliance on these forward-looking statements. Although we believe that our plans, intentions and expectations
reflected in or suggested by the forward-looking statements we make in this report are reasonable, we can give no assurance that these
plans, intentions or expectations will be achieved. These statements may be found under “Management’s Discussion and Analysis
of Financial Condition and Results of Operations,” as well as in this report generally. Actual events or results may differ
materially from those discussed in forward-looking statements as a result of various factors. In light of these risks and uncertainties,
there can be no assurance that the forward-looking statements contained in this filing will in fact occur.
Organizational History
OriginClear was founded
in 2007 under the name OriginOil® and began trading on the OTC markets in 2008. In 2015, the company rebranded as OriginClear®
to reflect its evolving mission of developing breakthrough businesses in the industrial water sector. Today, OriginClear operates as the
Clean Water Innovation Hub™ (“CWIB”), leveraging its expertise in retail investor development to bring potentially disruptive
water technologies s to market. Currently, OriginClear is focused on advancing the success of its subsidiary, Water On Demand, Inc. (WODI).
In 2023,
OriginClear consolidated three of its operating units into the WODI subsidiary in anticipation of a merger with Fortune Rise
Acquisition Corp (“FRLA”) a Special Purpose Acquisition Company. The definitive merger agreement between WODI and FRLA
was announced on October 24, 2023:
https://www.originclear.com/company-news/originclears-water-on-demand-and-fortune-rise-acquisition-corporation-announce-business-combination-to-create-nasdaq-listed-company.
WODI comprises three
distinct operating units, Modular Water Systems (“MWS”), Progressive Water Treatment (“PWT”), and Water on Demand
(“WOD”), the tlatter being a development-stage business.
| ● | PWT: This unit generates a significant portion of the
Company’s revenue by providing engineered water treatment solutions and custom treatment systems. |
| ● | MWS: Water On Demand Inc. holds an exclusive master
license to the intellectual property (IP) of Daniel M. Early, which includes five patents and related intellectual property, know-how
and trade secrets (“Early IP”). In April 2023, an independent valuation of the Early IP estimated its nominal value between
$26.6 million and $53.2 million. MWS’s product offerings are uniquely differentiated by this IP, further enhanced by additional
proprietary knowledge. . |
| ● | WOD: This unit in development aims to offer private
businesses water self-sustainability as a service – allowing them to pay for water treatment and purification services on a per-gallon
basis – a model commonly known as Design-Build-Own-Operate (“DBOO”). |
Water Businesses
As the Clean Water Innovation
Hub™ (“CWIB”), the Company is focused on developing and incubating businesses that create valuable properties within
the water industry and beyond. The mission of CWIB is to drive innovation through an incubation process that results in a launch of impactful
spinoffs, contributing to the global water industry.
Currently, OriginClear’s
mission as CWIB is to:
| 1. | Support the Post-Merger Rollout of the WODI: OriginClear will assist in the transition of
WODI post-merger, including a proposed management services contract with WODI. This contract is intended to be phased out over time
as WODI establishes its own internal team and capabilities. |
| 2. | Facilitate WODI’s Acquisition Strategy: OriginClear
is actively supporting WODI in executing its planned aggressive acquisitions plan, both before and after the SPAC merger (noting that
there is no assurance of success for either the merger or planned acquisitions); |
| 3. | Initiate Non-Binding Acquisition Agreements: OriginClear
is working to secure non-binding agreements for WODI or the post-merger entity to acquire related businesses, contingent upon the outcome
of the Business Combination Agreement ("BCA") process. |
| 4. | Accelerate New Business Ventures: For its own account,
OriginClear aims to accelerate the creation of new businesses, as it did with MWS in 2018 and with WOD in 2021, or through strategic
acquisitions, as it did with PWT in 2015. In this new phase, the Company may also explore projects outside the water industry. |
On April 2, 2024 OCLN
announced a strategic partnership with entrepreneur Kevin Harrington, a co-founding board member of the Entrepreneur’s Organization,
to elevate global awareness of OriginClear's Regulation A crowdfunding campaign, which is currently in registration.
www.originclear.com/company-news/its-official-investors-can-now-join-kevin-harrington-the-original-shark-on-shark-tank-to-champion-water-innovation/
www.sec.gov/Archives/edgar/data/1419793/000109690624001442/ocln_1aa.htm
Kevin Harrington, through
Kevin Harrington Enterprises, is compensated with fees and options to purchase stock in OriginClear, Inc. and Water On Demand, Inc.
Water On Demand
The Company is developing an outsourced water
treatment business called Water On Demand (“WOD”), which is operated through its subsidiary, Water on Demand, Inc. (“WODI”).
The WOD model aims to provide private businesses with water self-sustainability as a service, allowing them to pay for water treatment
and purification services on a per-gallon basis. A percentage of net profits from this service is planned to be distributed to investors
and stakeholders. This model, commonly referred to as Design-Build-Own-Operate or “DBOO”, is currently under evaluation through
pilot opportunities. These pilots will explore outsourced water treatment as a managed service, offering an alternative to significant
up-front capital investment for in-house wastewater treatment. Recently, the Company announced agreements with Enviromaintenance, a water
services company, and Klir, a utility network software provider, to develop a WOD commercial pilot in the Mobile Home Park (MHP) sector.
WODI intends to delegate the servicing and maintaining
of the units it builds, to established service organizations under long-term contracts. On April 6, 2022, WODI reached an agreement in
principle with its first intended contractor, Envirogen Technologies (www.envirogen.com), a 30-year international provider of environmental
technology and process solutions (www.originclear.com/company-news/originclear-and-envirogen-to-partner-on-water-on-demand). A second
partnership was initiated with service provider, Enviromaintenance (see below). While future resources for maintaining and servicing these
systems may come from acquisitions, no such acquisitions are actively being planned at this time.
WODI believes the delegation
of service and maintenance to long-term partners strategy could enable rapid scaling of the WOD program, while also creating a significant
barrier to entry for potential competitors. WODI may also license its designs to local water equipment companies, reserving for itself
what it believes is the highly-scalable (and profitable) fintech role.
At the time of this filing, the WOD division of
WODI has no dedicated staff or independent resources. WODI’s other divisions, PWT and MWS, employ a total of 32 people. The Board
of Directors of OriginClear serves as the Board for WODI, with OriginClear’s CEO and CFO also serving in those roles for WODI. Under
a planned management services arrangement, OCLN plans to provide WODI with staffing and administrative resources, in exchange for funding
related to WODI’s prospective merger with FRLA and certain special distributions.
On February 15, 2024, the Company and
Fortune Rise Acquisition Corporation (Nasdaq: FRLA), a Special Purpose Acquisition Company (SPAC), announced the filing of a
registration statement on Form S-4 with the SEC which includes a preliminary proxy statement and prospectus in connection with the
proposed business combination with OCLN subsidiary Water On Demand (WODI), an investor-funded service offering decentralized water
management solutions and technologies to businesses and communities, potentially without the burden of upfront capital expenditures.
WODI is a subsidiary of OriginClear, Inc. (OTC Other: OCLN). https://www.originclear.com/company-news/originclears-water-on-demand-and-fortune-rise-acquisition-corporation-seek-to-combine-under-form-s-4-registration-statement.
On March 26, 2024, the Company announced the signing
of a Memorandum of Understanding (MOU) between MWS and Enviromaintenance of Georgetown, TX, to collaborate on the planned Water On Demand
pilot program focusing on MHP in the Greater Central Texas Region. https://www.originclear.com/company-news/originclears-modular-water-systems-and-enviromaintenance-partner-for-water-on-demand-pilot-program
On April 9, 2024, the Company announced the selection
of Klir, Inc. (www.klir.com) to support its planned Water On Demand pilot program, also focusing on MHP in the Greater Central Texas Region.
https://www.originclear.com/company-news/modular-water-systems-and-klir-partner-for-water-on-demand-pilot-program.
Progressive Water Treatment Inc.
PWT is a
Dallas-based company specializing in the design, construction and service of a wide range of industrial water treatment
applications. PWT aims to provide a comprehensive, end-to-end solution to meet growing corporate demand for outsourced water
treatment services. Recently, PWT moved from its McKinney, TX headquarters to a new headquarters located at 5225 W Houston St,
Sherman TX 75092. A grand opening is scheduled for August 27, 2024.
PWT designs and manufactures
a complete line of water treatment systems for municipal, industrial and pure water applications. What sets PWT apart is its ability to
thoroughly understand each customer’s unique needs and then design and deliver a turnkey water treatment system that integrates
multiple technologies, resulting in a complete and tailored solution.
PWT utilizes a diverse
array of technologies in its turnkey systems, including chemical injection, media filtrations, membrane technology, ion exchange and SCADA
(supervisory control and data acquisition) systems. In addition to system design and construction, PWT offers a broad range of services,
including maintenance contracts, retrofits, and replacement assistance. PWT rents equipment under contracts of varying duration.
PWT primarily serves
customers in the United States and Canada, but its reach extends globally with projects ranging from Siberia to Argentina to the Middle
East.
Modular Water Systems
MWS offers a distinctive
line of prefabricated water transport and treatment systems. The division is led by Daniel “Dan” Early, a Professional Engineer
("Early"). On June 25, 2018, Early granted the Company a worldwide, exclusive, non-transferable license to the technology and
knowhow behind MWS (See “Intellectual Property”). A consulting agreement between the Company and Early also provided for assignment
of inventions from that date. A ten-year renewal on May 20, 2020 expanded the right to include sublicensing rights and the ability to
create manufacturing joint ventures. On 9 June 2023, Early signed a new, ten-year license agreement with WODI which assigned these rights
to WODI and updated Early's terms of compensation.
MWS, with PWT and other
companies as fabricators and assemblers, designs, manufactures, and delivers prefabricated water transport systems, including pump and
lift stations under the EveraMOD™ brand, as well as wastewater treatment plant (“WWTP”) products under the EveraSKID™
and EveraTREAT™ brands. These systems serve customers and end-users who need to treat their own wastewater, such as schools, small
communities, institutional facilities, real estate developments, factories, and industrial parks.
On August 12, 2022, the
Company announced the inaugural delivery and installation of its pre-engineered EveraBOX™ , which implements a low-risk Liquid Ammonium
Sulfate (LAS) disinfectant system for Pennsylvania’s Beaver Falls Municipal Water Authority (BFMA). As with otherMWS products, EveraBOX
is manufactured using cost-effective, durable materials such as High-Density Polyethylene (HDPE) or Polypropylene (PP) materials, also
known as Structural Reinforced Thermoplastic Pipe (SRTP). These materials have shown resilience against supply chain challenges affecting
metal and fiberglass construction.
On January 10, 2024,
OCLN Plastic Welding and Fabrication, Ltd. (PWF) of Buda, Texas, jointly announced a MOU for a strategic partnership between OriginClear’s
subsidiary, WODI, and PWF. https://www.originclear.com/company-news/originclears-water-on-demand-in-strategic-partnership-with-the-intent-to-acquire-manufacturer-for-its-proprietary-modular-products.
PWF is already a key
fabricator of highly durable, patent-based enclosures for MWS, the technology division of WODI that designs and develops scalable systems
for self-contained water treatment and transportation. This MOU strengthens the strategic relationship, enabling MWS to build its complete
water systems on-site where the enclosures are manufactured, ensuring maximum efficiency and speed.
Additionally, the parties
signed a Letter of Intent (LOI) outlining a framework to negotiate a definitive agreement for WODI to acquire PWF. If completed, this
acquisition would establish the first in-house manufacturing facility for WODI’s MWS division, with the expectation that it be accretive.
However, the parties caution that negotiations are in an early stage and may not succeed.
On March 26, 2024, OCLN
announced the signing of a MOU between MWS and Enviromaintenance of Georgetown, TX, to collaborate on the sales of standardized systems
in the Greater Central Texas Region, from Waco to San Antonio. Enviromaintenance (www.enviromaintenance.com) is a leading provider of
large community scale-on-site wastewater treatment and disposal systems, with a significant market presence in the MHP industry in the
greater Austin area. The company plans to recommend MWS’s fully integrated, modular wastewater treatment systems to MHPs and other
commercial water users, offering owners an affordable, reliable and efficient way to treat their wastewater.
https://www.originclear.com/company-news/originclears-modular-water-systems-and-enviromaintenance-partner-for-water-on-demand-pilot-program.
Patents and Intellectual
Property
On June 25, 2018, Dan
Early granted the Company a worldwide, exclusive, non-transferable license to intellectual property, which includes five issued U.S. patents,
as well as design software, CAD files, marketing materials, and design and specification documents (collectively referred to as “Early
IP”).
On May 20, 2020, the
license was renewed for an additional ten years, with the possibility of three-year extensions. The renewal also granted the Company the
rights to sublicense the Early IP, and, with approval, to establish ISO-compliant manufacturing joint ventures.
As part of the sale of
MWS assets to WODI on April 14, 2023, the license to the Early IP was included. On 9 June 2023, Early signed a new, ten-year license agreement
with WODI which assigned these rights to WODI and updated Early's terms of compensation.
The Early IP consists
of combined protection on the materials and configurations of complete packaged water treatment systems, built into containers. The patents
consist of the following:
# | |
Description | |
Patent No. | |
Date Patent Issued | |
Expiration Date |
1 | |
Wastewater System & Method | |
US 8,372,274 B2 Applications: WIPO, Mexico | |
02/12/13 | |
07/16/31 |
2 | |
Steel Reinforced HDPE Rainwater Harvesting | |
US 8,561,633 B2 | |
10/22/13 | |
05/16/32 |
3 | |
Wastewater Treatment System CIP | |
US 8,871,089 B2 | |
10/28/14 | |
05/07/32 |
4 | |
Scum Removal System for Liquids | |
US 9,205,353 B2 | |
12/08/15 | |
02/19/34 |
5 | |
Portable, Steel Reinforced HDPE Pump Station CIP | |
US 9,217,244 B2 | |
12/22/15 | |
10/20/31 |
On May 10, 2021, OCLN
announced the filing of a patent application titled “System And Method For Water Treatment Incentive”, which utilizes blockchain
technology and non-fungible tokens (NFT) to streamline the distribution of payments for outsourced water treatment and purification services,
billed on a pay-per-gallon basis ahead of inflation.
As demand grows for
localized, point-of-use or point-of-discharge water treatment solutions, the MWSlicensed IP family has become the foundation for a
portable, integrated, transportable, plug-and-play system. Unlike other packaged solutions, these systems can be manufactured in
series, having a longer lifespan and are more environmentally friendly.
The common feature of
this IP family is the use of Structural Reinforced ThermoPlastic, for the containers, that offers several advantages:
|
● |
Durability: An estimated life cycle of 75 to 100-year life years, compared to a few decades for metal and r 40 to 50 years for concrete. |
|
|
|
|
● |
Ease of Manufacture: The manufacturing process for these vessels can be automated. |
|
|
|
|
● |
Reliability: The materials are recyclable and can be made out of biomaterials. |
Patent No. 8,372,274
specifically relates to the use of vessels or containers made from this material, combined with a configuration of functional modules
or processes for general water treatment.
Although
Patent Nos. 8,561,633 and 8,871,089 have expired, the Company believes they may be reinstated. Patent No. 8,561,633 is a stormwater filtration
patent not directly related to the MWS business model, while, Patent No. 8,871,089 is a Continuation-in-Part (CIP) of the original Patent
No. 8,372,274. The original patent, along with Patent No. 9,217,244, forms the basis of the current MWS business, so the status of the
CIP is not considered material.
Subsequent patents, which
build upon the original claims, focus on more targeted applications. These patents describe specific combinations of modules engineered
within the vessel to address a specific water treatment challenges.
With the spinoff of WODI
and its operating divisions, the Company no longer holds patents directly but retains access to the licensed patents through WODI. The
licensed intellectual property includes five issued US patents, and design software, CAD files, marketing materials, and design and specification
documents. In addition, a consulting agreement with Early provides for assignment of inventions made since 2018.
On May 10, 2021, the
Company announced the filing of the “System And Method For Water Treatment Incentive” patent application, which uses blockchain
technology and non-fungible tokens (NFT) to facilitate the distribution of payments for outsourced water treatment and purification services
billed on a pay-per-gallon basis ahead of inflation. The application is currently provisional.
The ORIGINCLEAR trademark application was registered
as U.S. Trademark Registration 7,296,730, issued on February 6, 2024. Additionally, the ORIGINCLEAR logo trademark application was registered
as U.S. Trademark Registration 7,296,731, issued on February 6, 2024.
Other trademarks in process of registration include:
OriginClear Inc. filings
| ● | THE WATER COIN FOR THE WORLD |
| | |
| ● | THE CLEAN WATER INNOVATION HUB |
| | |
Water on Demand Inc. filings
The Company relies on, and expects to continue to relying on, a combination
of confidentiality agreements with employees, consultants, and third parties, as well as trademark, copyright, patent, trade secret,
and domain name protection laws, to protect its proprietary rights.
New Role of the Company
In its role as the CWIB,
the Company aims to create, incubate, and accelerate businesses in the water industry, and potentially expand into other sectors.
Following the successful
spinoff of its three major properties into a company that achieved a $32 million valuation in the BCA on October 24, 2023, the Company
now intends to replicate similar successes with other ventures. In these new ventures, the Company may take an equity position, in addition
to charging management fees.
The Company’s primary
strength lies in its ability to help capitalize these businesses through retail corporate development activities, guide them to achieve
commercial proof of concept and scalability, and to assist with mergers and acquisitions.
However, the Company
cautions that identifying suitable candidates for this new role may be challenging. Even if such candidates are identified, there is no
guarantee they will become partners or achieve commercial success. For the foreseeable future, The Company remains focused on financing,
developing, and supporting of its subsidiary, WODI.
Critical Accounting Policies
The
Securities and Exchange Commission (“SEC”) defines “critical accounting policies” as those that require application
of management’s most difficult, subjective or complex judgments, often as a result of the need to make estimates about the effect
of matters that are inherently uncertain and may change in subsequent periods. Not all of the accounting policies require management
to make difficult, subjective or complex judgments or estimates. However, the following policies could be deemed to be critical within
the SEC definition.
Revenue Recognition
We recognize revenue when
services are performed, and at the time of shipment of products, provided that evidence of an arrangement exists, title and risk of loss
have passed to the customer, fees are fixed or determinable, and collection of the related receivable is reasonably assured.
Revenues
and related costs on construction contracts are recognized as the performance obligations for work are satisfied over time in accordance
with Accounting Standards Codification (“ASC”) 606, Revenue from Contracts with Customers. Under ASC 606, revenue and associated
profit, will be recognized as the customer obtains control of the goods and services promised in the contract (i.e., performance obligations).
All un-allocable indirect costs and corporate general and administrative costs are charged to the periods as incurred. However, in the
event a loss on a contract is foreseen, the Company will recognize the loss as it is determined. Revisions in cost and profit estimates
during the course of the contract are reflected in the accounting period in which the facts for the revisions become known. Provisions
for estimated losses on uncompleted contracts are made in the period in which such losses are determined. Changes in job performance,
job conditions, and estimated profitability, including those arising from contract penalty provisions, and final contract settlements,
may result in revisions to costs and income, which are recognized in the period the revisions are determined.
Use of Estimates
The preparation of financial
statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect
the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities at the date of the financial statements,
and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. Significant
estimates include estimates used to review the Company’s goodwill, impairments and estimations of long-lived assets, revenue recognition
on percentage of completion type contracts, allowances for uncollectible accounts, inventory valuation, valuations of non-cash capital
stock issuances and the valuation allowance on deferred tax assets. The Company bases its estimates on historical experience and on various
other assumptions that the Company believes to be reasonable in the circumstances, the results of which form the basis for making judgments
about the carrying values of assets and liabilities that are not readily apparent from other sources. Actual results may differ from
these estimates under different assumptions or conditions.
Fair Value of Financial Instruments
Fair
value of financial instruments requires disclosure of the fair value information, whether or not recognized in the balance sheet, where
it is practicable to estimate that value. As of December 31, 2023, the amounts reported for cash, prepaid expenses, accounts payable
and accrued expenses approximate the fair value because of their short maturities.
Results of Operations
for the three months ended June 30, 2024 compared to the three months ended June 30, 2023.
Revenue and Cost
of Sales
Revenue
for the three months ended June 30, 2024 and 2023 was $0 and $6,573, respectively. Cost of sales for the three months ended June 30,2024
and 2023 was $6,552 and $6,463, respectively.
Selling and Marketing
Expenses
For the three months
ended June 30, 2024, we had selling and marketing expenses of $605,918, compared to $605,636 for the three months ended June 30, 2023.
The slight increase in selling and marketing expenses was primarily due to a rise in marketing activities, despite efforts to reduce overall
marketing expenses.
General and Administrative
Expenses
For the three months
ended June 30, 2024, we had general and administrative expenses of $730,573 compared to $638,601 for the three months ended June
30, 2023. The increase in general and administrative expenses was primarily due to an increase in outside services.
Other Income and
(Expenses)
Other income and (expenses)
increased by $9,673,874 to $6,606,244 for the three months ended June 30, 2024, compared to ($3,067,630) for the three months ended June
30, 2023. The increase was due primarily to an increase in loss on non-cash accounts associated with the change in fair value of the derivatives
in the amount of $7,223,181.
Net Income/(Loss)
Our net income (loss)
improved by $11,292,191 to $3,607,348 for the three months ended June 30, 2024, compared to net loss of $(7,684,843) for the three months
ended June 30, 2023. This significant improvement in net income is primarily attributable to an increase in other expenses associated
with the net change in fair value of derivative instruments, which are estimated each period.
The
estimates for fair value of derivative instruments are based on multiple inputs, including the market price of our stock, interest rates,
our stock price, volatility, variable conversion prices based on market prices defined in the respective agreements and probabilities
of certain outcomes based on managements’ estimates. These inputs are subject to significant changes from period to period, therefore,
the estimated fair value of the derivative liabilities will fluctuate from period to period, and the fluctuation may be material.
Results of Operations
for the six months ended June 30, 2024 compared to the six months ended June 30, 2023.
Revenue and Cost
of Sales
For
the six months ended June 30, 2024, we generated revenue of $6,573 compared to $13,146 for the six months ended June 30, 2023. The cost
of sales for the six months ended June 30, 2024, was $13,134 compared to $13,153 for the six months ended June 30, 2023.
Our
gross loss was $6,561 and $7 for the six months ended June 30, 2024 and 2023, respectively.
Selling and Marketing Expenses
For the six months ended
June 30, 2023, we had selling and marketing expenses of $1,132,558, compared to $1,402,255 for the six months ended June 30, 2022. The
decrease in selling and marketing expenses was primarily due to an decrease in marketing expenses.
General and Administrative
Expenses
General and administrative
expenses were $1,665,064 for the six months ended June 30, 2024, compared to $1,623,873 for the six months ended June 30, 2023. The
increase in general and administrative expenses was primarily due to professional and legal fees including non-cash, shares for services
expense and outside services.
Other Income and
(Expenses)
Other income and (expenses)
decreased by $13,396,311 resulting in a total of ($5,660,254) for the six months ended June 30, 2024, compared to $7,736,057 for the same
period in 2023. The significant decrease was primarily due to a reduction in the net change of derivative liability and conversion of
debt which declined by $9,419,390. Additionally, the impairment decreased by $50,000 and an decrease of $4,148,650 in the gain on conversion
of stock.
Net Income/(Loss)
Our net loss increased
by $7,686,127 to $(12,288,935) for the six months ended June 30, 2024, compared to net loss of $(4,602,808 for the six months ended June
30, 2023. The majority of the increase in net loss was due primarily to a decrease in the gain on the net change in derivative liability
and conversion of debt, which decreased by $9,419,390, and a decrease in interest and dividend expense by $109,978. Additionally, there
was a gain on the write-off of payable of $30,646 and a gain of $1,255,178 on the conversion of stock, both contributing positively to
other income (expense) for the six months ended June 30, 2024. These estimates are based on multiple inputs, including the market
price of our stock, interest rates, our stock price, volatility, variable conversion prices based on market prices defined in the respective
agreements and probabilities of certain outcomes based on managements’ estimates. These inputs are subject to significant changes
from period to period, therefore, the estimated fair value of the derivative liabilities will fluctuate from period to period, and the
fluctuation may be material.
Liquidity and Capital
Resources
Liquidity
is the ability of a company to generate funds to support its current and future operations, satisfy its obligations, and otherwise operate
on an ongoing basis. Significant factors in the management of liquidity are funds generated by operations, levels of accounts receivable
and accounts payable and capital expenditures.
The
condensed consolidated financial statements have been prepared on a going concern basis of accounting, which contemplates continuity
of operations, realization of assets and liabilities and commitments in the normal course of business. The accompanying condensed
consolidated financial statements do not reflect any adjustments that might result if the Company is unable to continue as a going concern. The
Company has not generated significant revenue, and has negative cash flows from operations, which raise substantial doubt about the Company’s
ability to continue as a going concern. The ability of the Company to continue as a going concern and appropriateness of using the going
concern basis is dependent upon, among other things, raising additional capital and increasing sales. We obtained funds from investors
during the six months ending June 30, 2024. No assurance can be given that any future financing will be available or, if available, that
it will be on terms that are satisfactory to the Company. Even if the Company is able to obtain additional financing, it may contain
restrictions on our operations, in the case of debt financing, or cause substantial dilution for our stockholders, in case of equity
financing.
In
connection with our prior sale of Series M Preferred Stock conducted under Regulation A under the Securities Act, we may be subject to
claims for rescission. If this occurs, it may have a negative effect on our liquidity.
As of June 30, 2024 and
December 31, 2023, we had cash and cash equivalents of $32,899 and $114,639, respectively. The working capital deficit was $42,253,425
on June 30, 2024, compared to $32,249,892 on December 31, 2023. The increase in working capital deficit was due primarily to an increase
in non-cash derivative liabilities, current liabilities held-for-sale, and accrued expenses, partially offset with a decrease in convertible
promissory notes.
During the period ended
June 30, 2024, we raised an aggregate of $575,100 from the sale of preferred stock in private placements and $2,468,730 from WODI convertible
secured promissory notes and warrants. Our ability to continue as a going concern is dependent upon raising capital from financing transactions
and future revenue.
Net cash used in operating
activities was $2,134,411 for the six months ended June 30, 2024, compared to $3,282,732 for the prior period ended June 30, 2023. The
decrease in net cash used in operating activities was primarily driven due to a significant gain on the net change in valuation of derivative
liabilities amounting to $6,593,511 in 2024 compared to a loss of $2,825,879 in 2023, contributing to reduced cash outflow. Additionally,
the impairment of receivable from SPAC decreased to $1,128,000 in 2024 from $2,650,986 in 2023.
Net
cash flows used in investing activities was $1,071,000 for the six months ended June 30, 2024, compared to $2,429,558 for the same period
in 2023. The decrease in cash used in investing activities was primarily due to a reduction in the purchase of SPAC notes payable, which
decreased to $1,128,000 in 2024 from $2,650,986 in 2023. Additionally, there were payments received in long-term assets amounting to $66,000
in 2024 compared to $230,428 in 2023.
Net cash flows provided
by financing activities was $2,952,125 for the six months ended June 30, 2024, as compared to $5,737,866 for same period in 2023. The
decrease in cash provided by financing activities was due to a reduction in proceeds from convertible secured promissory notes, which
decreased to $2,042,500 in 2024 from $4,994,000 in 2023. Additionally, there as an increase in payments on the line of credit and loans,
along with payments on cumulative preferred stock dividends and distributions.
Proceeds
from the issues of warrants in 2024 amounted to $426,230, which were not present in 2023. Net proceeds from the issuance of preferred
stock for cash increased to $575,100 in 2024 from $366,300 in 2023. To date, we have principally financed our operations through the sale
of our common and preferred stock and the issuance of debt.
We
do not have any material commitments for capital expenditures during the next twelve months. While the proceeds from the issuance of securities,
combined with revenue from operations, are currently sufficient to fund our operating expenses in the near term, we anticipate the need
to raise additional funds to sustain and expand our operations in the future. Therefore, our ability to continue operations is contingent
upon securing additional financing, which may not be available on acceptable terms, or at all.
Potential
financing transactions may include the issuance of equity or debt securities, obtaining credit facilities, or other financing mechanisms.
It’s important to note that if we do issue additional equity or debt securities, our stockholders may experience additional dilution
or the new equity securities may have rights, preferences or privileges senior to those of existing holders of our common stock.
The
inability to secure additional capital could significantly limit our ability to grow and might reduce our capacity to continue business
operations. In the event we are unable to obtain necessary financing, we may be forced to curtail our marketing and development plans
and possibly cease our operations.
We
have estimated our current average burn and believe that we have assets to ensure that we can function without liquidation for a limited
time, due to our cash on hand, growing revenue, and our ability to raise money from our investor base. Based on the aforesaid, we believe
we have the ability to continue our operations for the immediate future and will be able to realize assets and discharge liabilities
in the normal course of operations. However, there cannot be any assurance that any of the aforementioned assumptions will come to fruition
and as such we may only be able to function for a short time.
Off-Balance Sheet
Arrangements
We
do not have any off-balance sheet arrangements that are reasonably likely to have a current or future effect on our financial condition,
revenues, and results of operations, liquidity or capital expenditures.
ITEM 3. QUANTITATIVE
AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK
We
are a smaller reporting company as defined by Rule 12b-2 of the Exchange Act and are not required to provide the information under this
item.
ITEM 4. CONTROLS AND
PROCEDURES
Evaluation of Disclosure Controls and
Procedures
We
carried out an evaluation, under the supervision and with the participation of our management, including our principal executive officer
and principal financial officer, of the effectiveness of our disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e)
and 15d-15(e)). Based upon that evaluation, our principal executive officer and principal financial officer concluded that, as of the
end of the period covered in this report, our disclosure controls and procedures were effective to ensure that information required to
be disclosed in reports filed under the Exchange Act, is recorded, processed, summarized and reported within the required time periods
specified in the SEC’s rules and forms and is accumulated and communicated to our management, including our principal executive
officer and principal financial officer, as appropriate to allow timely decisions regarding required disclosure.
Changes in Internal Control Over Financial
Reporting
There
were no changes in the Company’s internal control over financial reporting (as defined in Rule 13a-15f of the Exchange Act) that
occurred during the fiscal quarter ended June 30, 2024 that has materially affected, or are reasonably likely to materially affect, the
our internal control over financial reporting.
Limitations on Internal Controls
In designing and evaluating
the disclosure controls and procedures, management recognizes that any controls and procedures, no matter how well designed and operated,
can provide only reasonable assurance of achieving the desired control objectives. In addition, the design of disclosure controls and
procedures must reflect the fact that there are resource constraints, and that management is required to apply its judgment in evaluating
the benefits of possible controls and procedures relative to their costs.
PART
II
Item 1. Legal
Proceedings.
There
are no material updates to the litigation matters with Process Solutions, Inc. as previously disclosed in the Form 10-K filed on April
18, 2024.
Item 1A. Risk Factors.
Not required for a smaller
reporting company.
Item 2. Unregistered
Sales of Equity Securities and Use of Proceeds.
None.
Item
3. Defaults Upon Senior Securities.
As
of the date of the filing of this report, the Company has 50 shares of Series F preferred stock outstanding which the Company failed
to redeem on September 1, 2020, for an aggregate redemption price (equal to the stated value) of $50,000.
As
of the date of the filing of this report, the Company has 25 shares of Series G preferred stock outstanding which the Company was required
to, and failed to redeem on April 30, 2021, for an aggregate redemption price (equal to the stated value) of $25,000.
As
of the date of the filing of this report, the Company has 25 shares of Series I preferred stock outstanding which the Company was required
to, and failed to redeem between May 2, 2021 and June 10, 2021, for an aggregate redemption price (equal to the stated value) of $25,000.
As
of the date of the filing of this report, the Company has 297 shares of Series K preferred stock outstanding which the Company was required
to, and failed to redeem between August 5, 2021 and March 26, 2022, for an aggregate redemption price (equal to the stated value) of
$297,150.
Item 4. Mine
Safety Disclosures
Not
applicable.
Item 5. Other
Information.
None.
Item 6. Exhibits.
SIGNATURES
Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by
the undersigned thereunto duly authorized.
August 14, 2024 |
ORIGINCLEAR,
INC. |
|
|
|
/s/
T. Riggs Eckelberry |
|
T. Riggs Eckelberry |
|
Chief Executive Officer |
|
(Principal Executive Officer)
and |
|
/s/
Prasad Tare |
|
Prasad Tare |
|
Chief Financial Officer |
|
(Principal Financial and Accounting Officer) |
45
NONE
315000000
315000000
1000
1000
1000
1000
160000000000
160000000000
0.00
0.00
0.00
0.01
0.00
0.00
0.00
0.01
0.00
0.01
0.01
0.01
1195322992
1243518367
1501184304
1558824206
1243518367
1501184304
false
--12-31
Q2
0001419793
0001419793
2024-01-01
2024-06-30
0001419793
2024-08-13
0001419793
2024-06-30
0001419793
2023-12-31
0001419793
us-gaap:SeriesFPreferredStockMember
2024-06-30
0001419793
us-gaap:SeriesFPreferredStockMember
2023-12-31
0001419793
us-gaap:SeriesGPreferredStockMember
2024-06-30
0001419793
us-gaap:SeriesGPreferredStockMember
2023-12-31
0001419793
ocln:SeriesI8PreferredStockMember
2024-06-30
0001419793
ocln:SeriesI8PreferredStockMember
2023-12-31
0001419793
ocln:SeriesK8PreferredStockMember
2024-06-30
0001419793
ocln:SeriesK8PreferredStockMember
2023-12-31
0001419793
us-gaap:OtherCurrentLiabilitiesMember
2024-06-30
0001419793
us-gaap:OtherCurrentLiabilitiesMember
2023-12-31
0001419793
us-gaap:OtherNoncurrentLiabilitiesMember
2024-06-30
0001419793
us-gaap:OtherNoncurrentLiabilitiesMember
2023-12-31
0001419793
ocln:SeriesJConvertiblePreferredStockMember
2024-06-30
0001419793
ocln:SeriesJConvertiblePreferredStockMember
2023-12-31
0001419793
ocln:SeriesLConvertiblePreferredStockMember
2024-06-30
0001419793
ocln:SeriesLConvertiblePreferredStockMember
2023-12-31
0001419793
ocln:SeriesMPreferredStockThreeMember
2024-06-30
0001419793
ocln:SeriesMPreferredStockThreeMember
2023-12-31
0001419793
ocln:SeriesMreferredStockMember
2024-06-30
0001419793
ocln:SeriesMreferredStockMember
2023-12-31
0001419793
ocln:SeriesO8ConvertiblePreferredStockMember
2024-06-30
0001419793
ocln:SeriesO8ConvertiblePreferredStockMember
2023-12-31
0001419793
ocln:SeriesPConvertiblePreferredStockMember
2024-06-30
0001419793
ocln:SeriesPConvertiblePreferredStockMember
2023-12-31
0001419793
ocln:SeriesQ12ConvertiblePreferredStockMember
2024-06-30
0001419793
ocln:SeriesQ12ConvertiblePreferredStockMember
2023-12-31
0001419793
ocln:SeriesR12ConvertiblePreferredStockMember
2024-06-30
0001419793
ocln:SeriesR12ConvertiblePreferredStockMember
2023-12-31
0001419793
ocln:SeriesS12ConvertiblePreferredStockMember
2024-06-30
0001419793
ocln:SeriesS12ConvertiblePreferredStockMember
2023-12-31
0001419793
ocln:SeriesUConvertiblePreferredStockMember
2024-06-30
0001419793
ocln:SeriesUConvertiblePreferredStockMember
2023-12-31
0001419793
ocln:SeriesW12ConvertiblePreferredStockMember
2024-06-30
0001419793
ocln:SeriesW12ConvertiblePreferredStockMember
2023-12-31
0001419793
ocln:SeriesYConvertiblePreferredStockMember
2024-06-30
0001419793
ocln:SeriesYConvertiblePreferredStockMember
2023-12-31
0001419793
us-gaap:SeriesDPreferredStockMember
2024-06-30
0001419793
us-gaap:SeriesDPreferredStockMember
2023-12-31
0001419793
us-gaap:SeriesCPreferredStockMember
2024-06-30
0001419793
us-gaap:SeriesCPreferredStockMember
2023-12-31
0001419793
2024-04-01
2024-06-30
0001419793
2023-04-01
2023-06-30
0001419793
2023-01-01
2023-06-30
0001419793
us-gaap:PreferredStockMember
2022-12-31
0001419793
ocln:MezzanineEquityMember
2022-12-31
0001419793
us-gaap:CommonStockMember
2022-12-31
0001419793
us-gaap:AdditionalPaidInCapitalMember
2022-12-31
0001419793
ocln:SubscriptionPayableMember
2022-12-31
0001419793
us-gaap:AccumulatedOtherComprehensiveIncomeMember
2022-12-31
0001419793
us-gaap:NoncontrollingInterestMember
2022-12-31
0001419793
us-gaap:RetainedEarningsMember
2022-12-31
0001419793
2022-12-31
0001419793
us-gaap:PreferredStockMember
2023-01-01
2023-06-30
0001419793
ocln:MezzanineEquityMember
2023-01-01
2023-06-30
0001419793
us-gaap:CommonStockMember
2023-01-01
2023-06-30
0001419793
us-gaap:AdditionalPaidInCapitalMember
2023-01-01
2023-06-30
0001419793
ocln:SubscriptionPayableMember
2023-01-01
2023-06-30
0001419793
us-gaap:AccumulatedOtherComprehensiveIncomeMember
2023-01-01
2023-06-30
0001419793
us-gaap:NoncontrollingInterestMember
2023-01-01
2023-06-30
0001419793
us-gaap:RetainedEarningsMember
2023-01-01
2023-06-30
0001419793
ocln:SeriesOPreferredStockMember
us-gaap:PreferredStockMember
2023-01-01
2023-06-30
0001419793
ocln:SeriesOPreferredStockMember
ocln:MezzanineEquityMember
2023-01-01
2023-06-30
0001419793
ocln:SeriesOPreferredStockMember
us-gaap:CommonStockMember
2023-01-01
2023-06-30
0001419793
ocln:SeriesOPreferredStockMember
us-gaap:AdditionalPaidInCapitalMember
2023-01-01
2023-06-30
0001419793
ocln:SeriesOPreferredStockMember
ocln:SubscriptionPayableMember
2023-01-01
2023-06-30
0001419793
ocln:SeriesOPreferredStockMember
us-gaap:AccumulatedOtherComprehensiveIncomeMember
2023-01-01
2023-06-30
0001419793
ocln:SeriesOPreferredStockMember
us-gaap:NoncontrollingInterestMember
2023-01-01
2023-06-30
0001419793
ocln:SeriesOPreferredStockMember
us-gaap:RetainedEarningsMember
2023-01-01
2023-06-30
0001419793
ocln:SeriesOPreferredStockMember
2023-01-01
2023-06-30
0001419793
ocln:SeriesQPreferredStockMember
us-gaap:PreferredStockMember
2023-01-01
2023-06-30
0001419793
ocln:SeriesQPreferredStockMember
ocln:MezzanineEquityMember
2023-01-01
2023-06-30
0001419793
ocln:SeriesQPreferredStockMember
us-gaap:CommonStockMember
2023-01-01
2023-06-30
0001419793
ocln:SeriesQPreferredStockMember
us-gaap:AdditionalPaidInCapitalMember
2023-01-01
2023-06-30
0001419793
ocln:SeriesQPreferredStockMember
ocln:SubscriptionPayableMember
2023-01-01
2023-06-30
0001419793
ocln:SeriesQPreferredStockMember
us-gaap:AccumulatedOtherComprehensiveIncomeMember
2023-01-01
2023-06-30
0001419793
ocln:SeriesQPreferredStockMember
us-gaap:NoncontrollingInterestMember
2023-01-01
2023-06-30
0001419793
ocln:SeriesQPreferredStockMember
us-gaap:RetainedEarningsMember
2023-01-01
2023-06-30
0001419793
ocln:SeriesQPreferredStockMember
2023-01-01
2023-06-30
0001419793
ocln:SeriesRPreferredStockMember
us-gaap:PreferredStockMember
2023-01-01
2023-06-30
0001419793
ocln:SeriesRPreferredStockMember
ocln:MezzanineEquityMember
2023-01-01
2023-06-30
0001419793
ocln:SeriesRPreferredStockMember
us-gaap:CommonStockMember
2023-01-01
2023-06-30
0001419793
ocln:SeriesRPreferredStockMember
us-gaap:AdditionalPaidInCapitalMember
2023-01-01
2023-06-30
0001419793
ocln:SeriesRPreferredStockMember
ocln:SubscriptionPayableMember
2023-01-01
2023-06-30
0001419793
ocln:SeriesRPreferredStockMember
us-gaap:AccumulatedOtherComprehensiveIncomeMember
2023-01-01
2023-06-30
0001419793
ocln:SeriesRPreferredStockMember
us-gaap:NoncontrollingInterestMember
2023-01-01
2023-06-30
0001419793
ocln:SeriesRPreferredStockMember
us-gaap:RetainedEarningsMember
2023-01-01
2023-06-30
0001419793
ocln:SeriesRPreferredStockMember
2023-01-01
2023-06-30
0001419793
ocln:SeriesSPreferredStockMember
us-gaap:PreferredStockMember
2023-01-01
2023-06-30
0001419793
ocln:SeriesSPreferredStockMember
ocln:MezzanineEquityMember
2023-01-01
2023-06-30
0001419793
ocln:SeriesSPreferredStockMember
us-gaap:CommonStockMember
2023-01-01
2023-06-30
0001419793
ocln:SeriesSPreferredStockMember
us-gaap:AdditionalPaidInCapitalMember
2023-01-01
2023-06-30
0001419793
ocln:SeriesSPreferredStockMember
ocln:SubscriptionPayableMember
2023-01-01
2023-06-30
0001419793
ocln:SeriesSPreferredStockMember
us-gaap:AccumulatedOtherComprehensiveIncomeMember
2023-01-01
2023-06-30
0001419793
ocln:SeriesSPreferredStockMember
us-gaap:NoncontrollingInterestMember
2023-01-01
2023-06-30
0001419793
ocln:SeriesSPreferredStockMember
us-gaap:RetainedEarningsMember
2023-01-01
2023-06-30
0001419793
ocln:SeriesSPreferredStockMember
2023-01-01
2023-06-30
0001419793
ocln:SeriesUPreferredStockMember
us-gaap:PreferredStockMember
2023-01-01
2023-06-30
0001419793
ocln:SeriesUPreferredStockMember
ocln:MezzanineEquityMember
2023-01-01
2023-06-30
0001419793
ocln:SeriesUPreferredStockMember
us-gaap:CommonStockMember
2023-01-01
2023-06-30
0001419793
ocln:SeriesUPreferredStockMember
us-gaap:AdditionalPaidInCapitalMember
2023-01-01
2023-06-30
0001419793
ocln:SeriesUPreferredStockMember
ocln:SubscriptionPayableMember
2023-01-01
2023-06-30
0001419793
ocln:SeriesUPreferredStockMember
us-gaap:AccumulatedOtherComprehensiveIncomeMember
2023-01-01
2023-06-30
0001419793
ocln:SeriesUPreferredStockMember
us-gaap:NoncontrollingInterestMember
2023-01-01
2023-06-30
0001419793
ocln:SeriesUPreferredStockMember
us-gaap:RetainedEarningsMember
2023-01-01
2023-06-30
0001419793
ocln:SeriesUPreferredStockMember
2023-01-01
2023-06-30
0001419793
ocln:SeriesYPreferredStockMember
us-gaap:PreferredStockMember
2023-01-01
2023-06-30
0001419793
ocln:SeriesYPreferredStockMember
ocln:MezzanineEquityMember
2023-01-01
2023-06-30
0001419793
ocln:SeriesYPreferredStockMember
us-gaap:CommonStockMember
2023-01-01
2023-06-30
0001419793
ocln:SeriesYPreferredStockMember
us-gaap:AdditionalPaidInCapitalMember
2023-01-01
2023-06-30
0001419793
ocln:SeriesYPreferredStockMember
ocln:SubscriptionPayableMember
2023-01-01
2023-06-30
0001419793
ocln:SeriesYPreferredStockMember
us-gaap:AccumulatedOtherComprehensiveIncomeMember
2023-01-01
2023-06-30
0001419793
ocln:SeriesYPreferredStockMember
us-gaap:NoncontrollingInterestMember
2023-01-01
2023-06-30
0001419793
ocln:SeriesYPreferredStockMember
us-gaap:RetainedEarningsMember
2023-01-01
2023-06-30
0001419793
ocln:SeriesYPreferredStockMember
2023-01-01
2023-06-30
0001419793
ocln:SeriesZPreferredStockMember
us-gaap:PreferredStockMember
2023-01-01
2023-06-30
0001419793
ocln:SeriesZPreferredStockMember
ocln:MezzanineEquityMember
2023-01-01
2023-06-30
0001419793
ocln:SeriesZPreferredStockMember
us-gaap:CommonStockMember
2023-01-01
2023-06-30
0001419793
ocln:SeriesZPreferredStockMember
us-gaap:AdditionalPaidInCapitalMember
2023-01-01
2023-06-30
0001419793
ocln:SeriesZPreferredStockMember
ocln:SubscriptionPayableMember
2023-01-01
2023-06-30
0001419793
ocln:SeriesZPreferredStockMember
us-gaap:AccumulatedOtherComprehensiveIncomeMember
2023-01-01
2023-06-30
0001419793
ocln:SeriesZPreferredStockMember
us-gaap:NoncontrollingInterestMember
2023-01-01
2023-06-30
0001419793
ocln:SeriesZPreferredStockMember
us-gaap:RetainedEarningsMember
2023-01-01
2023-06-30
0001419793
ocln:SeriesZPreferredStockMember
2023-01-01
2023-06-30
0001419793
us-gaap:PreferredStockMember
2023-06-30
0001419793
ocln:MezzanineEquityMember
2023-06-30
0001419793
us-gaap:CommonStockMember
2023-06-30
0001419793
us-gaap:AdditionalPaidInCapitalMember
2023-06-30
0001419793
ocln:SubscriptionPayableMember
2023-06-30
0001419793
us-gaap:AccumulatedOtherComprehensiveIncomeMember
2023-06-30
0001419793
us-gaap:NoncontrollingInterestMember
2023-06-30
0001419793
us-gaap:RetainedEarningsMember
2023-06-30
0001419793
2023-06-30
0001419793
us-gaap:PreferredStockMember
2023-12-31
0001419793
ocln:MezzanineEquityMember
2023-12-31
0001419793
us-gaap:CommonStockMember
2023-12-31
0001419793
us-gaap:AdditionalPaidInCapitalMember
2023-12-31
0001419793
ocln:SubscriptionPayableMember
2023-12-31
0001419793
us-gaap:AccumulatedOtherComprehensiveIncomeMember
2023-12-31
0001419793
us-gaap:NoncontrollingInterestMember
2023-12-31
0001419793
us-gaap:RetainedEarningsMember
2023-12-31
0001419793
us-gaap:PreferredStockMember
2024-01-01
2024-06-30
0001419793
ocln:MezzanineEquityMember
2024-01-01
2024-06-30
0001419793
us-gaap:CommonStockMember
2024-01-01
2024-06-30
0001419793
ocln:SubscriptionPayableMember
2024-01-01
2024-06-30
0001419793
us-gaap:AccumulatedOtherComprehensiveIncomeMember
2024-01-01
2024-06-30
0001419793
us-gaap:NoncontrollingInterestMember
2024-01-01
2024-06-30
0001419793
us-gaap:RetainedEarningsMember
2024-01-01
2024-06-30
0001419793
us-gaap:AdditionalPaidInCapitalMember
2024-01-01
2024-06-30
0001419793
ocln:SeriesOPreferredStockMember
us-gaap:PreferredStockMember
2024-01-01
2024-06-30
0001419793
ocln:SeriesOPreferredStockMember
ocln:MezzanineEquityMember
2024-01-01
2024-06-30
0001419793
ocln:SeriesOPreferredStockMember
us-gaap:CommonStockMember
2024-01-01
2024-06-30
0001419793
ocln:SeriesOPreferredStockMember
us-gaap:AdditionalPaidInCapitalMember
2024-01-01
2024-06-30
0001419793
ocln:SeriesOPreferredStockMember
ocln:SubscriptionPayableMember
2024-01-01
2024-06-30
0001419793
ocln:SeriesOPreferredStockMember
us-gaap:AccumulatedOtherComprehensiveIncomeMember
2024-01-01
2024-06-30
0001419793
ocln:SeriesOPreferredStockMember
us-gaap:NoncontrollingInterestMember
2024-01-01
2024-06-30
0001419793
ocln:SeriesOPreferredStockMember
us-gaap:RetainedEarningsMember
2024-01-01
2024-06-30
0001419793
ocln:SeriesOPreferredStockMember
2024-01-01
2024-06-30
0001419793
ocln:SeriesQPreferredStockMember
us-gaap:PreferredStockMember
2024-01-01
2024-06-30
0001419793
ocln:SeriesQPreferredStockMember
ocln:MezzanineEquityMember
2024-01-01
2024-06-30
0001419793
ocln:SeriesQPreferredStockMember
us-gaap:CommonStockMember
2024-01-01
2024-06-30
0001419793
ocln:SeriesQPreferredStockMember
us-gaap:AdditionalPaidInCapitalMember
2024-01-01
2024-06-30
0001419793
ocln:SeriesQPreferredStockMember
ocln:SubscriptionPayableMember
2024-01-01
2024-06-30
0001419793
ocln:SeriesQPreferredStockMember
us-gaap:AccumulatedOtherComprehensiveIncomeMember
2024-01-01
2024-06-30
0001419793
ocln:SeriesQPreferredStockMember
us-gaap:NoncontrollingInterestMember
2024-01-01
2024-06-30
0001419793
ocln:SeriesQPreferredStockMember
us-gaap:RetainedEarningsMember
2024-01-01
2024-06-30
0001419793
ocln:SeriesQPreferredStockMember
2024-01-01
2024-06-30
0001419793
ocln:SeriesRPreferredStockMember
us-gaap:PreferredStockMember
2024-01-01
2024-06-30
0001419793
ocln:SeriesRPreferredStockMember
ocln:MezzanineEquityMember
2024-01-01
2024-06-30
0001419793
ocln:SeriesRPreferredStockMember
us-gaap:CommonStockMember
2024-01-01
2024-06-30
0001419793
ocln:SeriesRPreferredStockMember
us-gaap:AdditionalPaidInCapitalMember
2024-01-01
2024-06-30
0001419793
ocln:SeriesRPreferredStockMember
ocln:SubscriptionPayableMember
2024-01-01
2024-06-30
0001419793
ocln:SeriesRPreferredStockMember
us-gaap:AccumulatedOtherComprehensiveIncomeMember
2024-01-01
2024-06-30
0001419793
ocln:SeriesRPreferredStockMember
us-gaap:NoncontrollingInterestMember
2024-01-01
2024-06-30
0001419793
ocln:SeriesRPreferredStockMember
us-gaap:RetainedEarningsMember
2024-01-01
2024-06-30
0001419793
ocln:SeriesRPreferredStockMember
2024-01-01
2024-06-30
0001419793
ocln:SeriesSPreferredStockMember
us-gaap:PreferredStockMember
2024-01-01
2024-06-30
0001419793
ocln:SeriesSPreferredStockMember
ocln:MezzanineEquityMember
2024-01-01
2024-06-30
0001419793
ocln:SeriesSPreferredStockMember
us-gaap:CommonStockMember
2024-01-01
2024-06-30
0001419793
ocln:SeriesSPreferredStockMember
us-gaap:AdditionalPaidInCapitalMember
2024-01-01
2024-06-30
0001419793
ocln:SeriesSPreferredStockMember
ocln:SubscriptionPayableMember
2024-01-01
2024-06-30
0001419793
ocln:SeriesSPreferredStockMember
us-gaap:AccumulatedOtherComprehensiveIncomeMember
2024-01-01
2024-06-30
0001419793
ocln:SeriesSPreferredStockMember
us-gaap:NoncontrollingInterestMember
2024-01-01
2024-06-30
0001419793
ocln:SeriesSPreferredStockMember
us-gaap:RetainedEarningsMember
2024-01-01
2024-06-30
0001419793
ocln:SeriesSPreferredStockMember
2024-01-01
2024-06-30
0001419793
ocln:SeriesWPreferredStockMember
us-gaap:PreferredStockMember
2024-01-01
2024-06-30
0001419793
ocln:SeriesWPreferredStockMember
ocln:MezzanineEquityMember
2024-01-01
2024-06-30
0001419793
ocln:SeriesWPreferredStockMember
us-gaap:CommonStockMember
2024-01-01
2024-06-30
0001419793
ocln:SeriesWPreferredStockMember
us-gaap:AdditionalPaidInCapitalMember
2024-01-01
2024-06-30
0001419793
ocln:SeriesWPreferredStockMember
ocln:SubscriptionPayableMember
2024-01-01
2024-06-30
0001419793
ocln:SeriesWPreferredStockMember
us-gaap:AccumulatedOtherComprehensiveIncomeMember
2024-01-01
2024-06-30
0001419793
ocln:SeriesWPreferredStockMember
us-gaap:NoncontrollingInterestMember
2024-01-01
2024-06-30
0001419793
ocln:SeriesWPreferredStockMember
us-gaap:RetainedEarningsMember
2024-01-01
2024-06-30
0001419793
ocln:SeriesWPreferredStockMember
2024-01-01
2024-06-30
0001419793
ocln:SeriesYPreferredStockMember
us-gaap:PreferredStockMember
2024-01-01
2024-06-30
0001419793
ocln:SeriesYPreferredStockMember
ocln:MezzanineEquityMember
2024-01-01
2024-06-30
0001419793
ocln:SeriesYPreferredStockMember
us-gaap:CommonStockMember
2024-01-01
2024-06-30
0001419793
ocln:SeriesYPreferredStockMember
us-gaap:AdditionalPaidInCapitalMember
2024-01-01
2024-06-30
0001419793
ocln:SeriesYPreferredStockMember
ocln:SubscriptionPayableMember
2024-01-01
2024-06-30
0001419793
ocln:SeriesYPreferredStockMember
us-gaap:AccumulatedOtherComprehensiveIncomeMember
2024-01-01
2024-06-30
0001419793
ocln:SeriesYPreferredStockMember
us-gaap:NoncontrollingInterestMember
2024-01-01
2024-06-30
0001419793
ocln:SeriesYPreferredStockMember
us-gaap:RetainedEarningsMember
2024-01-01
2024-06-30
0001419793
ocln:SeriesYPreferredStockMember
2024-01-01
2024-06-30
0001419793
us-gaap:PreferredStockMember
2024-06-30
0001419793
ocln:MezzanineEquityMember
2024-06-30
0001419793
us-gaap:CommonStockMember
2024-06-30
0001419793
us-gaap:AdditionalPaidInCapitalMember
2024-06-30
0001419793
ocln:SubscriptionPayableMember
2024-06-30
0001419793
us-gaap:AccumulatedOtherComprehensiveIncomeMember
2024-06-30
0001419793
us-gaap:NoncontrollingInterestMember
2024-06-30
0001419793
us-gaap:RetainedEarningsMember
2024-06-30
0001419793
ocln:SeriesTPreferredStockMember
2021-03-01
2021-03-01
0001419793
2021-03-01
2021-03-01
0001419793
us-gaap:CommonStockMember
2021-03-01
0001419793
2021-03-01
0001419793
country:AR
2021-03-01
0001419793
2021-07-01
2021-07-31
0001419793
srt:MinimumMember
2021-07-01
2021-07-31
0001419793
country:AR
2022-12-31
0001419793
country:AR
2022-01-01
2022-12-31
0001419793
2022-01-01
2022-12-31
0001419793
srt:MinimumMember
2022-01-01
2022-12-31
0001419793
2023-04-08
0001419793
2023-04-08
2023-04-08
0001419793
2023-06-21
2023-06-21
0001419793
srt:MinimumMember
us-gaap:MachineryAndEquipmentMember
2024-06-30
0001419793
srt:MaximumMember
us-gaap:MachineryAndEquipmentMember
2024-06-30
0001419793
srt:MinimumMember
us-gaap:FurnitureAndFixturesMember
2024-06-30
0001419793
srt:MaximumMember
us-gaap:FurnitureAndFixturesMember
2024-06-30
0001419793
us-gaap:ComputerEquipmentMember
2024-06-30
0001419793
srt:MinimumMember
us-gaap:VehiclesMember
2024-06-30
0001419793
srt:MaximumMember
us-gaap:VehiclesMember
2024-06-30
0001419793
srt:MinimumMember
us-gaap:LandAndLandImprovementsMember
2024-06-30
0001419793
srt:MaximumMember
us-gaap:LandAndLandImprovementsMember
2024-06-30
0001419793
us-gaap:MachineryAndEquipmentMember
2024-06-30
0001419793
us-gaap:MachineryAndEquipmentMember
2023-12-31
0001419793
us-gaap:ComputerEquipmentMember
2023-12-31
0001419793
us-gaap:VehiclesMember
2024-06-30
0001419793
us-gaap:VehiclesMember
2023-12-31
0001419793
us-gaap:OtherMachineryAndEquipmentMember
2024-06-30
0001419793
us-gaap:OtherMachineryAndEquipmentMember
2023-12-31
0001419793
us-gaap:FurnitureAndFixturesMember
2024-06-30
0001419793
us-gaap:FurnitureAndFixturesMember
2023-12-31
0001419793
us-gaap:LeaseholdImprovementsMember
2024-06-30
0001419793
us-gaap:LeaseholdImprovementsMember
2023-12-31
0001419793
us-gaap:FairValueMeasurementsRecurringMember
2024-06-30
0001419793
us-gaap:FairValueInputsLevel1Member
us-gaap:FairValueMeasurementsRecurringMember
2024-06-30
0001419793
us-gaap:FairValueInputsLevel2Member
us-gaap:FairValueMeasurementsRecurringMember
2024-06-30
0001419793
us-gaap:FairValueInputsLevel3Member
us-gaap:FairValueMeasurementsRecurringMember
2024-06-30
0001419793
srt:MinimumMember
us-gaap:MeasurementInputRiskFreeInterestRateMember
2024-06-30
0001419793
srt:MaximumMember
us-gaap:MeasurementInputRiskFreeInterestRateMember
2024-06-30
0001419793
srt:MinimumMember
us-gaap:MeasurementInputOptionVolatilityMember
2024-06-30
0001419793
srt:MaximumMember
us-gaap:MeasurementInputOptionVolatilityMember
2024-06-30
0001419793
srt:MinimumMember
us-gaap:MeasurementInputExpectedTermMember
2024-06-30
0001419793
srt:MaximumMember
us-gaap:MeasurementInputExpectedTermMember
2024-06-30
0001419793
us-gaap:MeasurementInputExpectedDividendRateMember
2024-06-30
0001419793
ocln:WaterOnDemandIncMember
2023-10-24
2023-10-24
0001419793
us-gaap:DiscontinuedOperationsHeldforsaleMember
2024-06-30
0001419793
us-gaap:DiscontinuedOperationsHeldforsaleMember
2023-12-31
0001419793
ocln:NetLossFromAssetsHeldForSaleMember
2024-01-01
2024-06-30
0001419793
ocln:NetLossFromAssetsHeldForSaleMember
2023-01-01
2023-06-30
0001419793
srt:DirectorMember
us-gaap:SeriesCPreferredStockMember
2017-03-14
0001419793
us-gaap:SeriesCPreferredStockMember
2017-03-14
2017-03-14
0001419793
us-gaap:SeriesCPreferredStockMember
2017-03-14
0001419793
srt:ChiefExecutiveOfficerMember
us-gaap:SeriesCPreferredStockMember
2024-06-30
0001419793
us-gaap:SeriesDPreferredStockMember
2018-04-13
0001419793
srt:MinimumMember
us-gaap:SeriesDPreferredStockMember
2018-04-13
0001419793
srt:MaximumMember
us-gaap:SeriesDPreferredStockMember
2018-04-13
0001419793
us-gaap:SeriesFPreferredStockMember
2018-08-14
0001419793
us-gaap:SeriesFPreferredStockMember
2018-08-14
2018-08-14
0001419793
us-gaap:SeriesFPreferredStockMember
2024-01-01
2024-06-30
0001419793
us-gaap:SeriesGPreferredStockMember
2019-01-16
0001419793
us-gaap:SeriesGPreferredStockMember
2019-01-16
2019-01-16
0001419793
ocln:SeriesIPreferredStockMember
2019-04-03
0001419793
ocln:SeriesIPreferredStockMember
2019-04-03
2019-04-03
0001419793
ocln:SeriesIPreferredStockMember
2024-06-30
0001419793
ocln:SeriesJPreferredStockMember
2019-04-03
0001419793
ocln:SeriesJPreferredStockMember
2024-06-30
0001419793
ocln:SeriesKPreferredStockMember
2019-06-03
0001419793
ocln:SeriesKPreferredStockMember
2019-06-03
2019-06-03
0001419793
ocln:SeriesKPreferredStockMember
2024-06-30
0001419793
ocln:SeriesWPreferredStockMember
2024-06-30
0001419793
ocln:SeriesLPreferredStockMember
2019-06-03
0001419793
ocln:SeriesLPreferredStockMember
2024-06-30
0001419793
ocln:SeriesMPreferredStockThreeMember
2020-07-01
0001419793
ocln:SeriesMPreferredStockThreeMember
2020-07-01
2020-07-01
0001419793
ocln:SeriesMPreferredStockThreeMember
2024-01-01
2024-06-30
0001419793
ocln:SeriesOReferredStockMember
2020-04-27
0001419793
ocln:SeriesOReferredStockMember
2020-04-27
2020-04-27
0001419793
2020-04-27
2020-04-27
0001419793
ocln:SeriesOReferredStockMember
2024-01-01
2024-06-30
0001419793
srt:MinimumMember
ocln:SeriesOReferredStockMember
2024-06-30
0001419793
srt:MaximumMember
ocln:SeriesOReferredStockMember
2024-06-30
0001419793
ocln:SeriesOReferredStockMember
2024-06-30
0001419793
ocln:SeriesOPreferredStockMember
2024-06-30
0001419793
ocln:SeriesPPreferredStocksMember
2020-04-27
0001419793
ocln:SeriesPPreferredStocksMember
2020-04-27
2020-04-27
0001419793
ocln:SeriesPPreferredStocksMember
2024-06-30
0001419793
ocln:SeriesQPreferredStockMember
2020-08-21
0001419793
ocln:SeriesQPreferredStockMember
2020-08-21
2020-08-21
0001419793
srt:MinimumMember
ocln:SeriesQPreferredStockMember
2020-08-21
0001419793
srt:MaximumMember
ocln:SeriesQPreferredStockMember
2020-08-21
0001419793
ocln:SeriesQPreferredStockMember
2024-06-30
0001419793
ocln:SeriesRPreferredStockMember
2020-11-16
0001419793
ocln:SeriesRPreferredStockMember
2020-11-15
2020-11-16
0001419793
srt:MinimumMember
ocln:SeriesRPreferredStockMember
2020-11-16
0001419793
srt:MaximumMember
ocln:SeriesRPreferredStockMember
2020-11-15
2020-11-16
0001419793
ocln:SeriesRPreferredStockMember
2024-06-30
0001419793
ocln:SeriesSPreferredStockMember
2021-02-05
0001419793
ocln:SeriesSPreferredStockMember
2021-02-05
2021-02-05
0001419793
srt:MinimumMember
ocln:SeriesSPreferredStockMember
2021-02-05
0001419793
srt:MaximumMember
ocln:SeriesSPreferredStockMember
2021-02-05
0001419793
ocln:SeriesSPreferredStockMember
2024-06-30
0001419793
ocln:SeriesUPreferredStockMember
2021-05-26
0001419793
ocln:SeriesUPreferredStockMember
2021-05-26
2021-05-26
0001419793
srt:MinimumMember
ocln:SeriesUPreferredStockMember
2021-05-26
0001419793
srt:MaximumMember
ocln:SeriesUPreferredStockMember
2021-05-26
0001419793
ocln:SeriesUPreferredStockMember
us-gaap:CommonStockMember
2021-05-26
2021-05-26
0001419793
ocln:SeriesUPreferredStockMember
2024-06-30
0001419793
ocln:SeriesUPreferredStockMember
2024-01-01
2024-06-30
0001419793
ocln:SeriesWPreferredStockMember
2021-04-28
0001419793
ocln:SeriesWPreferredStockMember
2021-04-28
2021-04-28
0001419793
ocln:SeriesYPreferredStockMember
2021-12-06
0001419793
srt:MinimumMember
ocln:SeriesYPreferredStockMember
2021-12-06
0001419793
srt:MaximumMember
ocln:SeriesYPreferredStockMember
2021-12-06
0001419793
ocln:SeriesYPreferredStockMember
2024-06-30
0001419793
srt:MinimumMember
ocln:SeriesYPreferredStockMember
2024-06-30
0001419793
srt:MaximumMember
ocln:SeriesYPreferredStockMember
2024-06-30
0001419793
ocln:SeriesZPreferredStockMember
2022-02-11
0001419793
ocln:SeriesZPreferredStockMember
2022-02-01
2022-02-11
0001419793
ocln:SeriesZPreferredStockMember
2022-02-18
0001419793
ocln:SeriesZPreferredStockMember
2023-01-01
2023-12-31
0001419793
ocln:SeriesZPreferredStockMember
2024-06-30
0001419793
ocln:SeriesZPreferredStockMember
2024-01-01
2024-06-30
0001419793
ocln:WODIMember
ocln:SeriesZPreferredStockMember
2024-01-01
2024-06-30
0001419793
ocln:WODIMember
2024-06-30
0001419793
ocln:WaterOnDemandIncWODIPreferredStockMember
2022-04-22
0001419793
ocln:OriginClearIncPreferredStockMember
us-gaap:SeriesBPreferredStockMember
2023-12-31
0001419793
ocln:OriginClearIncPreferredStockMember
us-gaap:SeriesBPreferredStockMember
2024-06-30
0001419793
ocln:OriginClearIncTechnologyMember
2024-01-01
2024-06-30
0001419793
ocln:FinancingAgreementMember
2024-06-30
0001419793
srt:MinimumMember
2024-06-30
0001419793
srt:MaximumMember
2024-06-30
0001419793
us-gaap:CommonStockMember
2024-01-01
2024-06-30
0001419793
ocln:ConversionPreferredStockMember
2024-01-01
2024-06-30
0001419793
us-gaap:CommonStockMember
2024-06-30
0001419793
us-gaap:ConvertibleNotesPayableMember
2023-01-01
2023-06-30
0001419793
us-gaap:ConvertibleNotesPayableMember
2023-06-30
0001419793
us-gaap:ConvertibleNotesPayableMember
2023-01-01
2023-06-30
0001419793
us-gaap:ConvertibleNotesPayableMember
2023-06-30
0001419793
srt:MaximumMember
2023-06-30
0001419793
srt:MinimumMember
2023-06-30
0001419793
ocln:SeriesOReferredStockMember
2023-01-01
2023-06-30
0001419793
ocln:ConversionAgreementMember
us-gaap:CommonStockMember
2023-01-01
2023-06-30
0001419793
ocln:ConversionPreferredStockMember
2023-01-01
2023-06-30
0001419793
ocln:WODIMember
2024-06-30
0001419793
ocln:OriginClearIncMember
2024-06-30
0001419793
ocln:PriorRegAHoldersMember
2024-06-30
0001419793
ocln:PriorSeriesAHoldersMember
2024-06-30
0001419793
ocln:PriorSeriesBHoldersMember
2024-06-30
0001419793
ocln:WODICommonStockHoldersMember
2024-06-30
0001419793
srt:ChiefExecutiveOfficerMember
ocln:RestrictedStockGrantAgreementsMember
2024-01-01
2024-06-30
0001419793
ocln:RestrictedStockGrantAgreementsMember
2024-01-01
2024-06-30
0001419793
us-gaap:WarrantMember
2024-06-30
0001419793
us-gaap:WarrantMember
2024-01-01
2024-06-30
0001419793
ocln:ZeroPointZeroTwoMember
2024-06-30
0001419793
srt:MinimumMember
ocln:ZeroPointZeroTwoMember
2024-01-01
2024-06-30
0001419793
ocln:ZeroPointOneMember
2024-06-30
0001419793
srt:MinimumMember
ocln:ZeroPointOneMember
2024-01-01
2024-06-30
0001419793
ocln:ZeroPointTwoFiveMember
2024-06-30
0001419793
srt:MinimumMember
ocln:ZeroPointTwoFiveMember
2024-01-01
2024-06-30
0001419793
ocln:ZeroPointZeroTwoSevenFiveMember
2024-06-30
0001419793
srt:MinimumMember
ocln:ZeroPointZeroTwoSevenFiveMember
2024-01-01
2024-06-30
0001419793
ocln:ZeroPointOneTwoFiveMember
2024-06-30
0001419793
srt:MinimumMember
ocln:ZeroPointOneTwoFiveMember
2024-01-01
2024-06-30
0001419793
ocln:OneMember
2024-06-30
0001419793
srt:MinimumMember
ocln:OneMember
2024-01-01
2024-06-30
0001419793
ocln:LongTermNotesTwoThousandFifteenMember
2024-06-30
0001419793
srt:MaximumMember
ocln:LongTermNotesTwoThousandFifteenMember
2024-06-30
0001419793
ocln:LongTermNotesTwoThousandFifteenMember
us-gaap:UnsecuredDebtMember
2024-06-30
0001419793
ocln:OriginalIssueDiscountNotesMember
2024-06-30
0001419793
ocln:OriginalIssueDiscountNotesMember
2024-01-01
2024-06-30
0001419793
ocln:OriginalIssueDiscountNotesMember
us-gaap:UnsecuredDebtMember
2024-06-30
0001419793
ocln:TwentyFifteenNotesMember
2015-08-31
0001419793
srt:MinimumMember
ocln:TwentyFifteenNotesMember
2024-01-01
2024-06-30
0001419793
srt:MaximumMember
ocln:TwentyFifteenNotesMember
2024-01-01
2024-06-30
0001419793
ocln:TwentyFifteenNotesMember
2024-06-30
0001419793
ocln:TwentyFifteenNotesMember
us-gaap:UnsecuredDebtMember
2024-06-30
0001419793
ocln:DecemberTwoZeroOneFiveNoteMember
2024-06-30
0001419793
ocln:DecemberTwoZeroOneFiveNoteMember
2024-06-30
0001419793
ocln:DecemberTwoZeroOneFiveNoteMember
us-gaap:ConvertibleDebtMember
2024-01-01
2024-06-30
0001419793
ocln:DecemberTwoZeroOneFiveNoteMember
us-gaap:ConvertibleNotesPayableMember
2024-06-30
0001419793
ocln:SeptemberTwoZeroOneSixNoteMember
2024-06-30
0001419793
ocln:SeptemberTwoZeroOneSixNoteMember
us-gaap:ConvertibleDebtMember
2024-01-01
2024-06-30
0001419793
ocln:SeptemberTwoZeroOneSixNoteMember
us-gaap:ConvertibleNotesPayableMember
2024-06-30
0001419793
ocln:Nov2020NoteMember
us-gaap:ConvertibleDebtMember
2020-11-19
0001419793
ocln:Nov2020NoteMember
2020-11-19
0001419793
ocln:Nov2020NoteMember
2020-11-19
2020-11-19
0001419793
ocln:Nov2020NoteMember
us-gaap:UnsecuredDebtMember
2024-06-30
0001419793
ocln:Jan2021NoteMember
us-gaap:ConvertibleDebtMember
2021-01-25
0001419793
ocln:Jan2021NoteMember
2021-01-25
0001419793
ocln:Jan2021NoteMember
2021-01-25
2021-01-25
0001419793
ocln:Jan2021NoteMember
us-gaap:UnsecuredDebtMember
2024-06-30
0001419793
us-gaap:ConvertibleNotesPayableMember
2024-06-30
0001419793
ocln:ConvertibleSecuredPromissoryNotesMember
2024-06-30
0001419793
us-gaap:SegmentContinuingOperationsMember
2024-06-30
0001419793
us-gaap:SegmentContinuingOperationsMember
2023-06-30
0001419793
us-gaap:SegmentDiscontinuedOperationsMember
2024-06-30
0001419793
us-gaap:SegmentDiscontinuedOperationsMember
2023-06-30
0001419793
us-gaap:ManufacturedProductOtherMember
2024-01-01
2024-06-30
0001419793
us-gaap:ManufacturedProductOtherMember
2023-01-01
2023-06-30
0001419793
ocln:ComponentSalesMember
2024-01-01
2024-06-30
0001419793
ocln:ComponentSalesMember
2023-01-01
2023-06-30
0001419793
ocln:PumpStationsMember
2024-01-01
2024-06-30
0001419793
ocln:PumpStationsMember
2023-01-01
2023-06-30
0001419793
ocln:WasteWaterTreatmentSystemsMember
2024-01-01
2024-06-30
0001419793
ocln:WasteWaterTreatmentSystemsMember
2023-01-01
2023-06-30
0001419793
us-gaap:ServiceMember
2024-01-01
2024-06-30
0001419793
us-gaap:ServiceMember
2023-01-01
2023-06-30
0001419793
us-gaap:ServiceOtherMember
2024-01-01
2024-06-30
0001419793
us-gaap:ServiceOtherMember
2023-01-01
2023-06-30
0001419793
us-gaap:RealEstateMember
2024-01-01
2024-06-30
0001419793
us-gaap:RealEstateMember
2023-01-01
2023-06-30
0001419793
ocln:OriginClearIncTechnologyMember
us-gaap:SeriesCPreferredStockMember
2018-05-15
0001419793
us-gaap:SeriesCPreferredStockMember
ocln:WTIICommonStockMember
2018-05-15
0001419793
ocln:OriginClearIncTechnologyMember
2018-05-15
0001419793
us-gaap:SeriesCPreferredStockMember
2018-05-15
2018-05-15
0001419793
ocln:WTIICommonStockMember
2021-11-12
2021-11-12
0001419793
us-gaap:SecuredDebtMember
2023-12-06
0001419793
us-gaap:NotesPayableOtherPayablesMember
2020-06-12
2020-06-12
0001419793
2024-05-13
2024-05-13
0001419793
2024-05-13
0001419793
ocln:WODIBoardMember
2022-11-16
0001419793
ocln:WODIBoardMember
2022-11-16
2022-11-16
0001419793
ocln:SponsorMember
2022-12-22
0001419793
ocln:SponsorMember
2022-12-22
2022-12-22
0001419793
ocln:FortuneRiseSponsorLLCMember
us-gaap:CommonClassBMember
2022-12-22
0001419793
ocln:FortuneRiseSponsorLLCMember
2022-12-22
2022-12-22
0001419793
ocln:FortuneRiseSponsorLLCMember
us-gaap:CommonClassBMember
2022-12-22
2022-12-22
0001419793
2022-11-04
0001419793
us-gaap:RelatedPartyMember
2022-12-31
0001419793
ocln:ConvertibleSecuredPromissoryNotesMember
ocln:WODIBoardMember
2022-12-22
0001419793
ocln:WaterOnDemandIncMember
2023-02-07
0001419793
2023-02-07
0001419793
ocln:FortuneRiseSponsorLLCMember
us-gaap:CommonClassAMember
2023-04-10
0001419793
ocln:FortuneRiseSponsorLLCMember
us-gaap:CommonClassBMember
2023-04-10
0001419793
2023-04-14
0001419793
ocln:WODIBoardMember
2024-06-30
0001419793
ocln:WODIMember
2024-01-01
2024-06-30
0001419793
ocln:FortuneRiseSponsorLLCMember
us-gaap:CommonClassAMember
2023-10-25
0001419793
ocln:FortuneRiseSponsorLLCMember
us-gaap:CommonClassBMember
2023-10-25
0001419793
ocln:FortuneRiseSponsorLLCMember
2023-10-25
2023-10-25
0001419793
ocln:WODIBoardMember
2024-01-01
2024-06-30
0001419793
us-gaap:SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember
2024-06-30
0001419793
ocln:WODIBoardMember
2023-01-01
2023-06-30
0001419793
ocln:ClassBFounderSharesMember
2023-06-30
0001419793
us-gaap:SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember
2023-06-30
0001419793
ocln:WODICommonStockMember
2024-01-01
2024-06-30
0001419793
us-gaap:ShareBasedCompensationAwardTrancheOneMember
2024-01-01
2024-06-30
0001419793
us-gaap:ShareBasedCompensationAwardTrancheTwoMember
2024-01-01
2024-06-30
0001419793
ocln:MergerPlanAgreementMember
2023-09-21
2023-09-21
0001419793
ocln:WODIRSGAsMember
2023-09-21
2023-09-21
0001419793
ocln:WODIRSGAsMember
2024-01-01
2024-06-30
0001419793
us-gaap:LineOfCreditMember
2023-12-31
0001419793
us-gaap:LineOfCreditMember
2023-01-01
2023-12-31
0001419793
us-gaap:LineOfCreditMember
2024-01-01
2024-06-30
0001419793
us-gaap:LineOfCreditMember
2024-06-30
0001419793
ocln:SeriesTPreferredStockMember
ocln:SpecialPurposeAgreementMember
2021-03-01
2021-03-01
0001419793
country:AR
ocln:SeriesTPreferredStockMember
2021-03-01
2021-03-01
0001419793
srt:MaximumMember
2021-01-01
2021-12-31
0001419793
srt:MinimumMember
2021-01-01
2021-12-31
0001419793
2021-01-01
2021-12-31
0001419793
srt:MaximumMember
country:AR
2022-01-01
2022-12-31
0001419793
srt:MinimumMember
country:AR
2022-01-01
2022-12-31
0001419793
2023-01-31
2023-01-31
0001419793
2023-01-31
0001419793
ocln:OCLNPreferredStockConversionsMember
us-gaap:SubsequentEventMember
2024-07-12
2024-08-01
0001419793
srt:MinimumMember
ocln:OCLNPreferredStockConversionsMember
us-gaap:SubsequentEventMember
2024-08-01
0001419793
srt:MaximumMember
ocln:OCLNPreferredStockConversionsMember
us-gaap:SubsequentEventMember
2024-08-01
0001419793
us-gaap:SubsequentEventMember
2024-07-03
2024-08-07
0001419793
us-gaap:SubsequentEventMember
2024-07-01
2024-07-30
0001419793
ocln:SeriesYPreferredStockMember
us-gaap:SubsequentEventMember
2024-07-01
2024-08-12
0001419793
us-gaap:InvestorMember
us-gaap:SubsequentEventMember
2024-08-12
xbrli:shares
iso4217:USD
iso4217:USD
xbrli:shares
xbrli:pure
utr:sqft
I, T. Riggs Eckelberry, certify that:
1. I have reviewed this quarterly report on Form 10-Q of OriginClear, Inc., for the quarter ended June 30, 2024;
2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
4. The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f) for the registrant and have:
(a) designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant is made known to us by others, particularly during the period in which this report is being prepared;
(b) designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
(c) evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
(d) disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and
5. The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent function):
(a) all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and
(b) any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.
1. I have reviewed this quarterly report on Form 10-Q of OriginClear, Inc., for the quarter ended June 30, 2024;
2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
4. The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f) for the registrant and have:
(a) designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant is made known to us by others, particularly during the period in which this report is being prepared;
(b) designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
(c) evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
(d) disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and
5. The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent function):
(a) all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and
(b) any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.
In connection with the Quarterly Report of OriginClear,
Inc. (the “Company”) on Form 10-Q for the quarter ended June 30, 2024 as filed with the Securities and Exchange Commission
on the date hereof (the “Report”), I, T. Riggs Eckelberry, Chief Executive Officer of the Company, certify, pursuant to 18
U.S.C. section 906 of the Sarbanes-Oxley Act of 2002, that:
(1) The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities and Exchange Act of 1934; and
(2) The information contained in the Report fairly presents, in all material respects, the financial condition and result of operations of the Company.
In connection with the Quarterly Report of OriginClear,
Inc. (the “Company”) on Form 10-Q for the quarter ended June 30, 2024 as filed with the Securities and Exchange Commission
on the date hereof (the “Report”), Prasad Tare, Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. section
906 of the Sarbanes-Oxley Act of 2002, that:
(1) The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities and Exchange Act of 1934; and
(2) The information contained in the Report fairly presents, in all material respects, the financial condition and result of operations of the Company.